<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Respir Crit Care Med</journal-id><journal-id journal-id-type="iso-abbrev">Am J Respir Crit Care Med</journal-id><journal-id journal-id-type="pmc-domain-id">465</journal-id><journal-id journal-id-type="pmc-domain">ajrccm</journal-id><journal-id journal-id-type="publisher-id">ajrccm</journal-id><journal-title-group><journal-title>American Journal of Respiratory and Critical Care Medicine</journal-title></journal-title-group><issn pub-type="ppub">1073-449X</issn><issn pub-type="epub">1535-4970</issn><publisher><publisher-name>American Thoracic Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10037482</article-id><article-id pub-id-type="pmcid-ver">PMC10037482.1</article-id><article-id pub-id-type="pmcaid">10037482</article-id><article-id pub-id-type="pmcaiid">10037482</article-id><article-id pub-id-type="pmid">36920066</article-id><article-id pub-id-type="doi">10.1164/rccm.202212-2216ST</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>American Thoracic Society Documents</subject></subj-group></article-categories><title-group><article-title>Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9663-2093</contrib-id><name name-style="western"><surname>Steiling</surname><given-names initials="K">Katrina</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9062-409X</contrib-id><name name-style="western"><surname>Kathuria</surname><given-names initials="H">Hasmeena</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0472-7894</contrib-id><name name-style="western"><surname>Echieh</surname><given-names initials="CP">Chidiebere Peter</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6351-5552</contrib-id><name name-style="western"><surname>Ost</surname><given-names initials="DE">David E.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3827-5010</contrib-id><name name-style="western"><surname>Rivera</surname><given-names initials="MP">M. Patricia</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5634-1638</contrib-id><name name-style="western"><surname>Begnaud</surname><given-names initials="A">Abbie</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6139-5320</contrib-id><name name-style="western"><surname>Celed&#243;n</surname><given-names initials="JC">Juan C.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8773-0425</contrib-id><name name-style="western"><surname>Charlot</surname><given-names initials="M">Marjory</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dietrick</surname><given-names initials="F">Frank</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7814-1773</contrib-id><name name-style="western"><surname>Duma</surname><given-names initials="N">Narjust</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6507-1403</contrib-id><name name-style="western"><surname>Fong</surname><given-names initials="KM">Kwun M.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7419-6091</contrib-id><name name-style="western"><surname>Ford</surname><given-names initials="JG">Jean G.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6749-8315</contrib-id><name name-style="western"><surname>Gould</surname><given-names initials="MK">Michael K.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0979-8234</contrib-id><name name-style="western"><surname>Holguin</surname><given-names initials="F">Fernando</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1577-2738</contrib-id><name name-style="western"><surname>P&#233;rez-Stable</surname><given-names initials="EJ">Eliseo J.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3768-1973</contrib-id><name name-style="western"><surname>Tanner</surname><given-names initials="NT">Nichole T.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5861-0683</contrib-id><name name-style="western"><surname>Thomson</surname><given-names initials="CC">Carey Conley</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7712-2135</contrib-id><name name-style="western"><surname>Wiener</surname><given-names initials="RS">Renda Soylemez</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0299-4582</contrib-id><name name-style="western"><surname>Wisnivesky</surname><given-names initials="J">Juan</given-names></name><on-behalf-of>on behalf of the American Thoracic Society Assembly on Thoracic Oncology</on-behalf-of></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>3</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><day>15</day><month>3</month><year>2023</year></pub-date><volume>207</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">431978</issue-id><fpage>e31</fpage><lpage>e46</lpage><pub-history><event event-type="pmc-release"><date><day>15</day><month>03</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>25</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-28 07:25:16.373"><day>28</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 by the American Thoracic Society</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>You may print one copy of this document at no charge. However, if you require more than one copy, you must place a reprint order. Domestic reprint orders: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:amy.schriver@sheridan.com">amy.schriver@sheridan.com</email>; international reprint orders: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:louisa.mott@springer.com">louisa.mott@springer.com</email>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="rccm.202212-2216ST.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="rccm.202212-2216ST.pdf"/><abstract><sec><title>Background</title><p>Lung nodules are common incidental findings, and timely evaluation is critical to ensure diagnosis of localized-stage and potentially curable lung cancers. Rates of guideline-concordant lung nodule evaluation are low, and the risk of delayed evaluation is higher for minoritized groups.</p></sec><sec><title>Objectives</title><p>To summarize the existing evidence, identify knowledge gaps, and prioritize research questions related to interventions to reduce disparities in lung nodule evaluation.</p></sec><sec><title>Methods</title><p>A multidisciplinary committee was convened to review the evidence and identify key knowledge gaps in four domains: <italic toggle="yes">1</italic>) research methodology, <italic toggle="yes">2</italic>) patient-level interventions, <italic toggle="yes">3</italic>) clinician-level interventions, and <italic toggle="yes">4</italic>) health system&#8211;level interventions. A modified Delphi approach was used to identify research priorities.</p></sec><sec><title>Results</title><p>Key knowledge gaps included <italic toggle="yes">1</italic>) a lack of standardized approaches to identify factors associated with lung nodule management disparities, <italic toggle="yes">2</italic>) limited data evaluating the role of social determinants of health on disparities in lung nodule management, <italic toggle="yes">3</italic>) a lack of certainty regarding the optimal strategy to improve patient&#8211;clinician communication and information transmission and/or retention, and <italic toggle="yes">4</italic>) a paucity of information on the impact of patient navigators and culturally trained multidisciplinary teams.</p></sec><sec><title>Conclusions</title><p>This statement outlines a research agenda intended to stimulate high-impact studies of interventions to mitigate disparities in lung nodule evaluation. Research questions were prioritized around the following domains: <italic toggle="yes">1</italic>) need for methodologic guidelines for conducting research related to disparities in nodule management, <italic toggle="yes">2</italic>) evaluating how social determinants of health influence lung nodule evaluation, <italic toggle="yes">3</italic>) studying approaches to improve patient&#8211;clinician communication, and <italic toggle="yes">4</italic>) evaluating the utility of patient navigators and culturally enriched multidisciplinary teams to reduce disparities.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>research priorities</kwd><kwd>lung nodule</kwd><kwd>pulmonary nodule</kwd><kwd>health disparities</kwd><kwd>health outcomes</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant"><funding-source country="US"><institution>American Thoracic Society</institution></funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><ref-count count="107"/><page-count count="15"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text position="float" orientation="portrait"><sec><title>Contents</title><list list-type="simple"><list-item><p>Overview</p><list list-type="simple"><list-item><p>Key Conclusions and Recommendations</p></list-item></list></list-item><list-item><p>Introduction</p></list-item><list-item><p>Methods</p></list-item><list-item><p>Results</p><list list-type="simple"><list-item><p>Considerations Related to Defining Disparities in Lung Nodule Evaluation and Research Methodology</p></list-item><list-item><p>Patient-Level Interventions</p></list-item><list-item><p>Interventions at the Clinician Level</p></list-item><list-item><p>Interventions at the Level of the Health System</p></list-item></list></list-item><list-item><p>Discussion</p></list-item></list></sec></boxed-text><sec><title>Overview</title><p>Lung nodules are common findings on diagnostic and screening computed tomography (CT) scans of the chest. National guidelines recommend algorithms to evaluate lung nodules because a subset are malignant. Although guideline-concordant lung nodule evaluation rates are low overall, the risk of suboptimal follow-up is higher for minoritized racial and ethnic groups. This research statement summarizes the existing evidence, identifies research gaps, and reports a formal consensus development process to prioritize future research questions in four domains related to interventions to mitigate health disparities in lung nodule evaluation: <italic toggle="yes">1</italic>) considerations regarding research methodology, <italic toggle="yes">2</italic>) interventions at the patient level, <italic toggle="yes">3</italic>) interventions at the clinician level, and <italic toggle="yes">4</italic>) interventions at the health-system level. This statement offers a research agenda to inform investigators and funding agencies on the considerations to generate high-priority, high-quality research on interventions to mitigate inequities in the evaluation of lung nodules.</p><sec><title>Key Conclusions and Recommendations</title><sec><title>Key knowledge gaps</title><p>
<list list-type="simple"><list-item><label>&#8226;</label><p>There is no standard approach to conducting studies identifying factors that contribute to disparities in lung nodule management and limited understanding of the underlying mechanisms of these disparities.</p></list-item><list-item><label>&#8226;</label><p>There are few data evaluating how social determinants of health (SDOH), communication and language barriers, or coexisting medical conditions contribute to disparities in lung nodule management and the optimal approaches to addressing these barriers.</p></list-item><list-item><label>&#8226;</label><p>Effective strategies to improve patient&#8211;clinician communication and address education barriers, limited English proficiency, and barriers related to low health literacy or numeracy to reduce disparities in lung nodule management are unclear.</p></list-item><list-item><label>&#8226;</label><p>The impact of interventions such as culturally enriched multidisciplinary teams and patient navigators on lung nodule evaluation disparities is unknown.</p></list-item><list-item><label>&#8226;</label><p>The optimal approach to tracking and arranging the evaluation of incidental lung nodules is unclear, particularly in high-risk settings for lack of follow-up, such as emergency departments.</p></list-item></list>
</p></sec><sec><title>Prioritized research questions and interventions to reduce disparities in lung nodule management</title><p>
<list list-type="simple"><list-item><label>1.</label><p>What research methods should be used to better document and define disparities in lung nodule management?</p></list-item><list-item><label>2.</label><p>How should we evaluate the effectiveness of appointment-level interventions and patient navigation?</p></list-item><list-item><label>3.</label><p>What is the effect of various communication strategies on information transmission and retention related to lung nodule management and the impact of these interventions on disparities in lung nodule evaluation?</p></list-item><list-item><label>4.</label><p>What is the impact of strategies that allocate resources such as navigators, interpreters, or transportation assistance to individuals at highest risk for not attending lung nodule follow-up visits?</p></list-item><list-item><label>5.</label><p>What are the optimal approaches for tracking lung nodule follow-up, and do these methods address disparities in lung nodule management?</p></list-item></list></p></sec><sec><title>Recommendations</title><p>
<list list-type="simple"><list-item><label>1.</label><p>Study design and analytic strategies should be selected to explicitly state assumptions, ensure adequate control for confounding, improve transparency, and facilitate comparison of results across studies.</p></list-item><list-item><label>2.</label><p>A national research agenda should include studies that better define disparities and evaluate the underlying mechanisms of disparities in lung nodule management, test the effectiveness of appointment-level interventions and patient navigation, assess resource allocation strategies, and evaluate innovative approaches to improving access to subspecialty expertise in resource-limited settings on disparities in lung nodule management.</p></list-item></list></p></sec></sec></sec><sec sec-type="intro"><title>Introduction</title><p>Lung nodules are common findings on diagnostic and screening CT scans of the chest (<xref rid="bib1" ref-type="bibr">1</xref>). Approximately 5% of individuals with lung nodules will ultimately receive diagnoses of lung cancer (<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>), the leading cause of cancer death in men and women in the United States (<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>) and globally (<xref rid="bib5" ref-type="bibr">5</xref>). Furthermore, lung cancer survival strongly depends on the stage at diagnosis (<xref rid="bib6" ref-type="bibr">6</xref>), and thus timely evaluation of lung nodules is key to achieving good long-term outcomes (<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>).</p><p>Health disparities in lung nodule follow-up and treatment are a major problem. Black patients have a higher risk of delayed follow-up for lung nodules (<xref rid="bib7" ref-type="bibr">7</xref>), and Latino/a individuals have lower rates of guideline-concordant follow-up for lung nodules (<xref rid="bib8" ref-type="bibr">8</xref>). In lung cancer screening, delayed or absent follow-up of screen-detected nodules occurred more frequently in Black individuals (<xref rid="bib9" ref-type="bibr">9</xref>&#8211;<xref rid="bib12" ref-type="bibr">12</xref>), those with mental health conditions or substance use disorders (<xref rid="bib9" ref-type="bibr">9</xref>), and those with lower incomes (<xref rid="bib9" ref-type="bibr">9</xref>). Delayed follow-up of lung nodules, which may represent lung malignancy, can disproportionately affect the health of communities with higher lung cancer rates (<xref rid="bib13" ref-type="bibr">13</xref>&#8211;<xref rid="bib17" ref-type="bibr">17</xref>) and contribute to known health disparities in lung cancer stage and survival (<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib18" ref-type="bibr">18</xref>). Although it is unclear if disparities in lung cancer similarly extend to evaluation of lung nodules, such care gaps could contribute to the lower rates of surgical intervention or complete resection and the higher lung cancer mortality in individuals who are Black, Latino/a, or of lower socioeconomic status (<xref rid="bib19" ref-type="bibr">19</xref>&#8211;<xref rid="bib25" ref-type="bibr">25</xref>).</p><p>This research statement discusses the methodology and development of a research priority agenda that identifies interventions and implementation strategies to mitigate health inequities in evaluating and managing lung nodules detected on diagnostic and screening CT scans. We used a health equity implementation framework (<xref rid="bib26" ref-type="bibr">26</xref>) and the cascade of care model (<xref rid="bib7" ref-type="bibr">7</xref>) to inform our recommendations regarding research priorities.</p></sec><sec sec-type="methods"><title>Methods</title><p>This American Thoracic Society (ATS) Assembly on Thoracic Oncology project was approved by the ATS Program Review Subcommittee. The chair (K.S.) and cochair (J.W.) convened a multidisciplinary, international committee of members representing pulmonary medicine, medical oncology, thoracic surgery, primary care, the patient experience, government funding agencies, urban and rural healthcare settings, academic institutions, and the Veterans Health Administration, as well as an unaffiliated clinician and a patient representative (<xref rid="tbl1" ref-type="table">Table 1</xref>). Committee members had expertise in health disparities, lung nodule evaluation, tobacco use, and lung cancer screening. Potential conflicts of interest were disclosed and managed per the policies and procedures of the ATS.</p><table-wrap position="float" id="tbl1" orientation="portrait"><label>
Table 1.
</label><caption><p>Committee Members and Areas of Expertise</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">Committee Member</th><th align="center" colspan="1" rowspan="1">Institution</th><th align="center" colspan="1" rowspan="1">Role</th><th align="center" colspan="1" rowspan="1">Area of Expertise</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">Katrina Steiling, M.D., M.Sc.</td><td align="left" colspan="1" rowspan="1">Boston University Chobanian &amp; Avedisian School of Medicine</td><td align="left" colspan="1" rowspan="1">Chair, member, clinician workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Lung cancer screening health disparities, implementation perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Juan Wisnivesky, M.D., Dr.P.H.</td><td align="left" colspan="1" rowspan="1">Icahn School of Medicine at Mount Sinai</td><td align="left" colspan="1" rowspan="1">Cochair, member, health systems workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Health disparities, primary care perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">David E. Ost, M.D., M.P.H.</td><td align="left" colspan="1" rowspan="1">MD Anderson Cancer Center</td><td align="left" colspan="1" rowspan="1">Moderator, patient workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Interventional pulmonary, disparities in lung cancer survival</td></tr><tr><td align="left" colspan="1" rowspan="1">M. Patricia Rivera, M.D.</td><td align="left" colspan="1" rowspan="1">University of Rochester Medical Center</td><td align="left" colspan="1" rowspan="1">Moderator, health systems workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Disparities in lung cancer screening</td></tr><tr><td align="left" colspan="1" rowspan="1">Nichole T. Tanner, M.D., M.S.C.R.</td><td align="left" colspan="1" rowspan="1">Medical University of South Carolina and Ralph H. Johnson VA Medical Center</td><td align="left" colspan="1" rowspan="1">Moderator, clinician workgroup</td><td align="left" colspan="1" rowspan="1">Disparities in lung cancer care</td></tr><tr><td align="left" colspan="1" rowspan="1">Abbie Begnaud, M.D.</td><td align="left" colspan="1" rowspan="1">University of Minnesota</td><td align="left" colspan="1" rowspan="1">Member, patient workgroup</td><td align="left" colspan="1" rowspan="1">Implementation of lung cancer screening in Native American communities, improving access to care in rural communities</td></tr><tr><td align="left" colspan="1" rowspan="1">Juan C. Celed&#243;n, M.D., Dr.P.H.</td><td align="left" colspan="1" rowspan="1">University of Pittsburgh</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Role of racial ancestry and genetics in pathogenesis of airway diseases</td></tr><tr><td align="left" colspan="1" rowspan="1">Marjory Charlot, M.D. M.P.H., M.Sc.</td><td align="left" colspan="1" rowspan="1">University of North Carolina Lineberger Comprehensive Cancer Center</td><td align="left" colspan="1" rowspan="1">Member, patient workgroup</td><td align="left" colspan="1" rowspan="1">Addressing disparities in cancer care, patient engagement, medical oncology perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Frank Dietrick, B.A.</td><td align="left" colspan="1" rowspan="1">Unaffiliated</td><td align="left" colspan="1" rowspan="1">Member, patient workgroup</td><td align="left" colspan="1" rowspan="1">Patient perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Narjust Duma, M.D.</td><td align="left" colspan="1" rowspan="1">Dana-Farber Cancer Institute</td><td align="left" colspan="1" rowspan="1">Member, clinician workgroup</td><td align="left" colspan="1" rowspan="1">Cancer care equity, medical oncology perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Chidiebere Peter Echieh, M.B. B.Ch., F.W.A.C.S.</td><td align="left" colspan="1" rowspan="1">University of Calabar Teaching Hospital</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Thoracic surgery, international perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Kwun M. Fong, M.B. B.S., Ph.D.</td><td align="left" colspan="1" rowspan="1">The Prince Charles Hospital and University of Queensland</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Lung cancer, international perspective</td></tr><tr><td align="left" colspan="1" rowspan="1">Jean G. Ford, M.D.</td><td align="left" colspan="1" rowspan="1">Unaffiliated</td><td align="left" colspan="1" rowspan="1">Member, clinician workgroup</td><td align="left" colspan="1" rowspan="1">Cancer screening disparities, minority participation in research</td></tr><tr><td align="left" colspan="1" rowspan="1">Michael K. Gould, M.D., M.S.</td><td align="left" colspan="1" rowspan="1">Kaiser Permanente Bernard J. Tyson School of Medicine</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Pulmonary nodule evaluation, health services research</td></tr><tr><td align="left" colspan="1" rowspan="1">Fernando Holguin, M.D.</td><td align="left" colspan="1" rowspan="1">University of Colorado School of Medicine</td><td align="left" colspan="1" rowspan="1">Member, clinician workgroup</td><td align="left" colspan="1" rowspan="1">Latino health disparities</td></tr><tr><td align="left" colspan="1" rowspan="1">Hasmeena Kathuria, M.D.</td><td align="left" colspan="1" rowspan="1">Boston University Chobanian &amp; Avedisian School of Medicine</td><td align="left" colspan="1" rowspan="1">Member, patient workgroup, Writing Committee</td><td align="left" colspan="1" rowspan="1">Tobacco treatment interventions, health disparities, ATS Tobacco Action Committee</td></tr><tr><td align="left" colspan="1" rowspan="1">Eliseo J. P&#233;rez-Stable, M.D.</td><td align="left" colspan="1" rowspan="1">NIMHD, NIH</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Health disparities; tobacco smoking; Latino health care; director, NIMHD</td></tr><tr><td align="left" colspan="1" rowspan="1">Carey Conley Thomson, M.D., M.P.H.</td><td align="left" colspan="1" rowspan="1">Mount Auburn Hospital; Havard Medical School</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Gender disparities in lung cancer, lung nodule evaluation</td></tr><tr><td align="left" colspan="1" rowspan="1">Renda Soylemez Wiener, M.D., M.P.H.</td><td align="left" colspan="1" rowspan="1">VA Boston Healthcare System; Boston University Chobanian &amp; Avedisian School of Medicine</td><td align="left" colspan="1" rowspan="1">Member, health systems workgroup</td><td align="left" colspan="1" rowspan="1">Lung nodule evaluation, VA Healthcare System perspective</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><italic toggle="yes">Definition of abbreviations</italic>: ATS&#8201;=&#8201;American Thoracic Society; NIMHD&#8201;=&#8201;National Institute on Minority Health and Health Disparities; VA&#8201;=&#8201;Veterans Health Administration.</p></fn></table-wrap-foot></table-wrap><p>The chair and cochair developed an overview of current knowledge gaps on disparities in nodule management. Because of the limited data available related to interventions to address this topic, the committee also reviewed studies on interventions in the context of lung cancer diagnosis and treatment, lung cancer screening, and related to the management and screening for other cancers (e.g., breast, colorectal, prostate).</p><p>The committee held two virtual meetings on April 19 and May 12, 2021, consisting of presentations and discussions focused on identifying existing evidence related to inequalities in lung nodule evaluation and interventions to address these disparities. A cascade-of-care framework (<xref rid="bib7" ref-type="bibr">7</xref>) was used to represent a patient&#8217;s journey from lung nodule detection to completion of recommended evaluation and to facilitate identification of areas in which care disruption could lead to management delays (<xref rid="fig1" ref-type="fig">Figure 1</xref>). This approach led to the identification of three key areas in a patient&#8217;s journey from lung nodule detection to completion of recommended evaluation where knowledge gaps existed and potential interventions could be targeted: the patient, clinician, and health-system levels. Virtual breakout sessions aligned with each of these focus areas were held on May 20, May 24, and May 26, 2021, led by designated moderators. Committee members were assigned to and attended specific workgroups (<xref rid="tbl1" ref-type="table">Table 1</xref>) but had the option to attend additional workgroups and view recordings of other workgroups asynchronously. Each of the three workgroups, led by a designated moderator (<xref rid="tbl1" ref-type="table">Table 1</xref>), discussed knowledge gaps and research questions related to interventions to address health disparities in the focus area. All three workgroups identified knowledge gaps related to research methodology and defining disparities in lung nodule evaluation. All breakout sessions discussed methodology challenges, which were combined into a fourth area of research questions. The chairs and moderators then drafted and refined research questions along four topic areas: <italic toggle="yes">1</italic>) research methodology, <italic toggle="yes">2</italic>) patient-level factors, <italic toggle="yes">3</italic>) clinician-level factors, and <italic toggle="yes">4</italic>) health system&#8211;level factors (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="fig1" orientation="portrait"><label>
Figure 1.
</label><caption><p>Cascade-of-care framework for identifying potential areas for intervention to reduce disparities in lung nodule evaluation. This figure shows each step of a patient&#8217;s path from lung nodule detection through completion of recommended follow-up. Delays of care could potentially be introduced at each step. Interventions to mitigate disparities in lung nodule evaluation might target each of these discrete steps at the patient, clinician, and/or system level. SDOH&#8201;=&#8201;social determinants of health.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="rccm.202212-2216STf1.jpg"/></fig><fig position="float" id="fig2" orientation="portrait"><label>
Figure 2.
</label><caption><p>Modified Delphi process for identifying research priorities. The chairs and designated moderators drafted research questions related to the four key topic areas. Then, research questions in each topic area were distributed to committee members as a survey with a seven-point Likert scale, with modifications during each subsequent round on the basis of the survey results. For the third and final survey round, committee members were asked to score the questions using a seven-point Likert scale and rank the questions in order of importance within each key topic area. Research questions were prioritized on the basis of the average Likert score from the final survey round, with ties broken by average ranking.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="rccm.202212-2216STf2.jpg"/></fig><p>Thirty-three questions were initially drafted (<xref rid="tbl2" ref-type="table">Table 2</xref>). A modified Delphi process was used for the whole committee to prioritize each question and to achieve consensus through subsequent online surveys (<xref rid="fig2" ref-type="fig">Figure 2</xref>). In the first round, committee members were asked to rate research questions from 1 (extremely unimportant) to 7 (extremely important). In round 1, most research questions were rated highly (&gt;80% ranked questions &gt;5, where 1&#8201;=&#8201;extremely unimportant, 2&#8201;=&#8201;unimportant, 3&#8201;=&#8201;somewhat unimportant, 4&#8201;=&#8201;neither important nor unimportant, 5&#8201;=&#8201;somewhat important, 6&#8201;=&#8201;important, and 7&#8201;=&#8201;extremely important). Although round 1 indicated that the committee was in consensus that most of the research questions were at least somewhat important (<xref rid="tbl2" ref-type="table">Table 2</xref>), having most questions rated highly hindered the committee&#8217;s ability to prioritize the research questions. Thus, we modified the degrees of the Likert scale in round 2 to better delineate the degree of importance (1&#8201;=&#8201;unimportant, 2&#8201;=&#8201;neither important nor unimportant, 3&#8201;=&#8201;maybe important, 4&#8201;=&#8201;somewhat important, 5&#8201;=&#8201;important, 6&#8201;=&#8201;very important, and 7&#8201;=&#8201;extremely important). Questions rated as important, very important, or extremely important were carried forward to the third round of voting. During this round, committee members were asked to rank the research questions for each topic area hierarchically and rate on the basis of importance using the same seven-point scale as in round 1. The final prioritization of the questions was generated on the basis of the average Likert score, with the average rank used to break ties.</p><table-wrap position="float" id="tbl2" orientation="portrait"><label>
Table 2.
</label><caption><p>Prioritization of Research Questions</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">First-Round Likert Score (<italic toggle="yes">Mean</italic> [<italic toggle="yes">SD</italic>])</th><th align="center" colspan="1" rowspan="1">Second-Round Likert Score (<italic toggle="yes">Mean</italic> [<italic toggle="yes">SD</italic>])</th><th align="center" colspan="1" rowspan="1">Third-Round Likert Score (<italic toggle="yes">Mean</italic> [<italic toggle="yes">SD</italic>])</th><th align="center" colspan="1" rowspan="1">Third-Round Average Rank</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1">Defining disparities and research methodology</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.5 (0.7)</td><td align="center" colspan="1" rowspan="1">6.2 (1.1)</td><td align="center" colspan="1" rowspan="1">6.6 (0.70)</td><td align="center" colspan="1" rowspan="1">1.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What systems need to be in place to identify patient factors that contribute to disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.1 (1.0)</td><td align="center" colspan="1" rowspan="1">5.6 (1.5)</td><td align="center" colspan="1" rowspan="1">6.0 (1.54)</td><td align="center" colspan="1" rowspan="1">2.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How can we best identify, document, and measure the degree of influence of patient (e.g., stigma, unmet social needs, language barriers) and clinician-level factors (e.g., implicit bias, cultural sensitivity) that may affect disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">5.7 (1.6)</td><td align="center" colspan="1" rowspan="1">5.5 (1.1)</td><td align="center" colspan="1" rowspan="1">5.9 (1.20)</td><td align="center" colspan="1" rowspan="1">3.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the optimal approaches to measuring patient-level and clinician-level factors that are associated with disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.1 (0.7)</td><td align="center" colspan="1" rowspan="1">5.6 (1.3)</td><td align="center" colspan="1" rowspan="1">5.7 (1.16)</td><td align="center" colspan="1" rowspan="1">3.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How do patient values affect lung nodule management? How can we account for differences in patient preferences and values when measuring adherence to lung nodule management recommendations?</td><td align="center" colspan="1" rowspan="1">6.0 (0.8)</td><td align="center" colspan="1" rowspan="1">5.5 (1.2)</td><td align="center" colspan="1" rowspan="1">5.7 (0.95)</td><td align="center" colspan="1" rowspan="1">4.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are patient values surrounding lung nodule management, and how much do they vary among individuals and among groups of individuals?</td><td align="center" colspan="1" rowspan="1">5.6 (0.9)</td><td align="center" colspan="1" rowspan="1">5.0 (1.4)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the optimal approaches for measuring the quality of patient&#8211;provider discussion and documentation of shared decision making for lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">5.4 (1.5)</td><td align="center" colspan="1" rowspan="1">5.00(1.1)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Are the types and extent of disparities observed in lung nodule management similar to or different than those observed in early-stage lung cancer and lung cancer screening?</td><td align="center" colspan="1" rowspan="1">5.4 (1.3)</td><td align="center" colspan="1" rowspan="1">4.5 (1.5)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Patient-level factors</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How do patients&#8217; social determinants of health influence lung nodule follow-up and/or provider interactions?</td><td align="center" colspan="1" rowspan="1">6.1 (0.8)</td><td align="center" colspan="1" rowspan="1">6.1 (1.0)</td><td align="center" colspan="1" rowspan="1">6.3 (0.67)</td><td align="center" colspan="1" rowspan="1">2.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What appointment-level interventions (e.g., telehealth, same-day evaluation, mobile imaging units) are most effective in improving disparities in timely lung nodule management? How does this vary across different settings (e.g., urban vs. rural)?</td><td align="center" colspan="1" rowspan="1">6.5 (0.7)</td><td align="center" colspan="1" rowspan="1">6.2 (1.1)</td><td align="center" colspan="1" rowspan="1">6.3 (0.82)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">3.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Does patient navigation affect disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.3 (0.8)</td><td align="center" colspan="1" rowspan="1">5.9 (1.1)</td><td align="center" colspan="1" rowspan="1">6.3 (0.82)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">3.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the optimal approaches to addressing communication and language barriers?</td><td align="center" colspan="1" rowspan="1">6.4 (0.7)</td><td align="center" colspan="1" rowspan="1">5.2 (1.2)</td><td align="center" colspan="1" rowspan="1">6.3 (0.82)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">4.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How do communication and language barriers affect lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.1 (0.9)</td><td align="center" colspan="1" rowspan="1">5.6 (0.8)</td><td align="center" colspan="1" rowspan="1">6.1 (0.88)</td><td align="center" colspan="1" rowspan="1">3.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How do patients&#8217; comorbidities influence lung nodule follow-up? How do they contribute to disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">5.8 (0.8)</td><td align="center" colspan="1" rowspan="1">5.1 (0.8)</td><td align="center" colspan="1" rowspan="1">5.8 (1.03)</td><td align="center" colspan="1" rowspan="1">4.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Does the use of community health workers or community nurse navigators improve patient&#8211;provider communication?</td><td align="center" colspan="1" rowspan="1">6.1 (0.7)</td><td align="center" colspan="1" rowspan="1">5.1 (1.2)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Does patient outreach via text messaging affect disparities in lung nodule evaluation?</td><td align="center" colspan="1" rowspan="1">5.8 (1.2)</td><td align="center" colspan="1" rowspan="1">5.1 (1.3)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How does immigration and documentation status influence lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">5.7 (0.8)</td><td align="center" colspan="1" rowspan="1">4.8 (1.6)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Clinician-level factors</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the strategies and/or interventions to improve patient&#8211;clinician communication (e.g., closed-loop communication), reduce disparities in lung nodule follow-up, and increase the accuracy of information transmission and information retention?</td><td align="center" colspan="1" rowspan="1">6.6 (0.6)</td><td align="center" colspan="1" rowspan="1">6.2 (1.0)</td><td align="center" colspan="1" rowspan="1">6.6 (0.52)</td><td align="center" colspan="1" rowspan="1">1.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How does implicit bias affect communication, time spent with patients, patient agreement to lung nodule follow-up, and adherence to lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">6.1 (0.8)</td><td align="center" colspan="1" rowspan="1">5.5 (1.5)</td><td align="center" colspan="1" rowspan="1">6.0 (1.41)</td><td align="center" colspan="1" rowspan="1">2.5</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the clinician characteristics (e.g., time after training, years of education, practice setting, race, and gender) that affect disparities in nodule follow-up? How do gender and perceived race concordance affect patient&#8211;clinician interactions (satisfaction, lung nodule follow-up)?</td><td align="center" colspan="1" rowspan="1">5.8 (0.9)</td><td align="center" colspan="1" rowspan="1">5.2 (1.3)</td><td align="center" colspan="1" rowspan="1">5.4 (0.70)</td><td align="center" colspan="1" rowspan="1">3.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Do interventions such as implicit bias training and/or culturally sensitive language training improve lung nodule follow-up? Do they improve disparities in lung nodule management? Do they improve patient/clinician interactions?</td><td align="center" colspan="1" rowspan="1">5.9 (1.5)</td><td align="center" colspan="1" rowspan="1">5.2 (1.9)</td><td align="center" colspan="1" rowspan="1">5.4 (1.51)</td><td align="center" colspan="1" rowspan="1">2.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How does hospital or clinic setting (e.g., academic vs. non-academic) affect disparities in lung nodule evaluation (e.g., access to diagnostic procedures, diagnostic biomarker testing, expert opinions)?</td><td align="center" colspan="1" rowspan="1">5.8 (1.0)</td><td align="center" colspan="1" rowspan="1">5.0 (0.9)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">System-level factors</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What interventions (e.g., culturally enriched multidisciplinary teams, nurse navigators, patient navigators) improve lung nodule evaluation and reduce disparities in lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">6.6 (0.6)</td><td align="center" colspan="1" rowspan="1">5.9 (1.2)</td><td align="center" colspan="1" rowspan="1">6.3 (0.82)</td><td align="center" colspan="1" rowspan="1">5.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What types of resource allocation strategies (e.g., machine learning, formulas, EHR) ensure that resources (e.g., patient navigators, translation services, transportation assistance) are allocated to individuals who have the highest risk of nonadherence to lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">5.9 (1.0)</td><td align="center" colspan="1" rowspan="1">5.8 (0.9)</td><td align="center" colspan="1" rowspan="1">6.2 (1.03)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">3.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What is the optimal method to track lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">6.1 (1.0)</td><td align="center" colspan="1" rowspan="1">5.9 (1.4)</td><td align="center" colspan="1" rowspan="1">6.2 (1.03)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">3.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How can we track and arrange follow-up for patients with incidental lung nodules found in settings more prone to loss of follow-up (e.g., emergency department, inpatient units)?</td><td align="center" colspan="1" rowspan="1">6.2 (1.0)</td><td align="center" colspan="1" rowspan="1">6.2 (0.9)</td><td align="center" colspan="1" rowspan="1">6.2 (0.79)</td><td align="center" colspan="1" rowspan="1">4.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are interventions (e.g., tele&#8211;tumor board), particularly at low-resource centers, that improve access to diagnostic procedures and subspecialty consultation to mitigate disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">6.4 (0.9)</td><td align="center" colspan="1" rowspan="1">5.9 (1.1)</td><td align="center" colspan="1" rowspan="1">6.1 (0.74)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">4.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What communication strategy (e.g., letter, telehealth, in person) is most effective to ensure individuals with low health literacy understand results and the importance of returning for follow-up?</td><td align="center" colspan="1" rowspan="1">6.5 (0.8)</td><td align="center" colspan="1" rowspan="1">5.9 (1.0)</td><td align="center" colspan="1" rowspan="1">6.1 (0.74)<xref rid="TF6" ref-type="table-fn">*</xref></td><td align="center" colspan="1" rowspan="1">6.3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What system-level changes (e.g., simplify algorithms for follow-up [similar to LCS], tracking) are most effective in overcoming delays in lung nodule care?</td><td align="center" colspan="1" rowspan="1">6.5 (0.7)</td><td align="center" colspan="1" rowspan="1">5.9 (1.2)</td><td align="center" colspan="1" rowspan="1">6.0 (0.94)</td><td align="center" colspan="1" rowspan="1">7.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How do system-level interventions such as after-visit summaries and automated reminders affect disparities in lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">5.6 (0.8)</td><td align="center" colspan="1" rowspan="1">5.6 (1.2)</td><td align="center" colspan="1" rowspan="1">5.9 (0.99)</td><td align="center" colspan="1" rowspan="1">4.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;What are the optimal approaches to measuring and quantifying cost-effectiveness and added value for infrastructure and personnel for improving disparities in lung nodule management?</td><td align="center" colspan="1" rowspan="1">5.5 (1.0)</td><td align="center" colspan="1" rowspan="1">5.0 (1.4)</td><td align="center" colspan="1" rowspan="1">5.5 (0.85)</td><td align="center" colspan="1" rowspan="1">6.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;How can we best develop educational content that is understandable for patients to improve lung nodule follow-up?</td><td align="center" colspan="1" rowspan="1">5.9 (1.0)</td><td align="center" colspan="1" rowspan="1">5.4 (1.1)</td><td align="center" colspan="1" rowspan="1">5.6 (0.84)</td><td align="center" colspan="1" rowspan="1">7.8</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Who (e.g., radiologist, technician, patient navigator, clinician) should discuss nodule results with socially disadvantaged individuals?</td><td align="center" colspan="1" rowspan="1">5.5 (0.9)</td><td align="center" colspan="1" rowspan="1">5.2 (1.3)</td><td align="center" colspan="1" rowspan="1">Dropped</td><td align="center" colspan="1" rowspan="1">&#160;</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p><italic toggle="yes">Definition of abbreviations</italic>: EHR&#8201;=&#8201;electronic health record; LCS&#8201;=&#8201;lung cancer screening.</p></fn><fn id="TF3"><p>Round 1 rating scale: 1&#8201;=&#8201;extremely unimportant, 2&#8201;=&#8201;unimportant, 3&#8201;=&#8201;somewhat unimportant, 4&#8201;=&#8201;neither unimportant nor important, 5&#8201;=&#8201;somewhat important, 6&#8201;=&#8201;important, 7&#8201;=&#8201;extremely important.</p></fn><fn id="TF4"><p>Round 2 rating scale: 1&#8201;=&#8201;unimportant, 2&#8201;=&#8201;neither unimportant nor important, 3&#8201;=&#8201;maybe important, 4&#8201;=&#8201;somewhat important, 5&#8201;=&#8201;important, 6&#8201;=&#8201;very important, 7&#8201;=&#8201;extremely important.</p></fn><fn id="TF5"><p>Round 3 rating scale: 1&#8201;=&#8201;extremely unimportant, 2&#8201;=&#8201;unimportant, 3&#8201;=&#8201;somewhat unimportant, 4&#8201;=&#8201;neither unimportant nor important, 5&#8201;=&#8201;somewhat important, 6&#8201;=&#8201;important, 7&#8201;=&#8201;extremely important.</p></fn><fn id="TF6"><label>*</label><p>Ties were broken by using the SD of the Likert scale rating. In the case of ties of both the average Likert score and its SD, the average ranking of the question was used to break the tie. For the patient domain (six questions in the final voting round, where the question ranked first was rated most important), questions related to appointment-level interventions were ranked 3.1, patient navigation 3.4, and communication or language barriers 4.1. For the health system domain (11 questions in the final voting round, where the question ranked first was rated most important), questions related to resource allocation strategies were ranked 3.6, methods for tracking follow-up 3.9, interventions for low-resource settings 4.9, and communication strategies for individuals with low literacy 6.3.</p></fn></table-wrap-foot></table-wrap><p>The chair and cochair drafted the initial version of the manuscript with assistance from a writing committee (C.P.E., H.K., D.E.O., and M.P.R.). The manuscript was then circulated to the full committee and iteratively revised. The ATS Board of Directors approved the final document.</p></sec><sec sec-type="results"><title>Results</title><p>We divide this section into four key topic areas for which research questions were identified: <italic toggle="yes">1</italic>) considerations related to defining disparities in lung nodule evaluation and research methodology to study this problem, <italic toggle="yes">2</italic>) interventions that act at the patient level, <italic toggle="yes">3</italic>) interventions that act at the clinician level, and <italic toggle="yes">4</italic>) interventions that act at the health-system level. In each of these four areas, we first summarize the evidence and knowledge gaps identified during the virtual breakout sessions and literature review. We then highlight our findings from the modified Delphi process used to prioritize the research questions.</p><sec><title>Considerations Related to Defining Disparities in Lung Nodule Evaluation and Research Methodology</title><sec><title>Summary of evidence and knowledge gaps related to defining disparities in lung nodule evaluation</title><p>Identifying the specific disparities and their underlying contributors could better inform the study of interventions to address these gaps in care. Although there are several studies describing disparities in lung cancer screening, lung cancer care, and lung cancer mortality, there are no current studies that address whether the same disparities exist in the evaluation of pulmonary nodules. For example, compared with non-Hispanic White individuals, minoritized groups are disproportionately affected by lung cancer and have worse outcomes (<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>), and Black individuals experience higher lung cancer rates than White individuals for equivalent cigarette smoke exposure (<xref rid="bib15" ref-type="bibr">15</xref>&#8211;<xref rid="bib17" ref-type="bibr">17</xref>). Similar disparities in lung cancer rates and survival exist for patients in rural locations (<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>). In addition, minoritized patient groups, including Black, American Indian and Alaskan Native individuals, tend to receive diagnoses of more advanced lung cancer, are less likely to undergo guideline-concordant treatment, and experience worse long-term survival (<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib18" ref-type="bibr">18</xref>). Black and Latino men are less likely to undergo any surgical intervention or complete resection for lung cancer than White men (<xref rid="bib19" ref-type="bibr">19</xref>&#8211;<xref rid="bib21" ref-type="bibr">21</xref>), raising the question of whether similar disparities exist in invasive diagnostic evaluations for suspicious lung nodules.</p><p>Although less studied in the published literature, disparities in lung nodule evaluation and lung cancer care may also affect other groups historically discriminated against because of age (<xref rid="bib29" ref-type="bibr">29</xref>), ethnicity (<xref rid="bib19" ref-type="bibr">19</xref>&#8211;<xref rid="bib25" ref-type="bibr">25</xref>), disability status (<xref rid="bib30" ref-type="bibr">30</xref>), sexual orientation and gender minority status (<xref rid="bib31" ref-type="bibr">31</xref>&#8211;<xref rid="bib34" ref-type="bibr">34</xref>), HIV status (<xref rid="bib35" ref-type="bibr">35</xref>), rural location (<xref rid="bib36" ref-type="bibr">36</xref>), and severe mental illness (<xref rid="bib37" ref-type="bibr">37</xref>&#8211;<xref rid="bib40" ref-type="bibr">40</xref>). For example, transgender individuals are less likely to undergo lung nodule evaluation (<xref rid="bib34" ref-type="bibr">34</xref>). Adults with severe mental illness such as schizophrenia are more likely to smoke cigarettes (<xref rid="bib37" ref-type="bibr">37</xref>, <xref rid="bib38" ref-type="bibr">38</xref>), less likely to quit smoking (<xref rid="bib39" ref-type="bibr">39</xref>), and experience higher lung cancer mortality associated with delays in diagnosis and treatment (<xref rid="bib40" ref-type="bibr">40</xref>). Women are more likely to undergo limited resection for localized-stage lung cancer than White men (<xref rid="bib19" ref-type="bibr">19</xref>). Understanding the causes of such disparities could inform interventions to improve lung nodule management.</p><p>Furthermore, the underlying mediators of disparities in lung nodule evaluation are unclear. For example, disparities in lung cancer screening, lung cancer care, or lung cancer mortality have been reported for historically discriminated groups other than racial and ethnic minoritized populations, including women (<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib29" ref-type="bibr">29</xref>), transgender individuals (<xref rid="bib34" ref-type="bibr">34</xref>), older adults, and adults with severe mental illnesses (<xref rid="bib41" ref-type="bibr">41</xref>&#8211;<xref rid="bib43" ref-type="bibr">43</xref>). Some of these inequalities may be explained by disparities in lung nodule evaluation. However, little is known about the causes of these disparities, making it challenging to determine which interventions might best support the clinical care of these patients.</p></sec><sec><title>Summary of evidence and knowledge gaps related to research methodology for studying disparities in lung nodule evaluation</title><p>All three workgroups identified and discussed factors related to research methodology that are critical to ensuring accurate, valid, and generalizable results from studies evaluating specific approaches to improve disparities in lung nodule evaluation. Although the existing literature does not recommend specific methods for designing studies to identify patient-, clinician-, or system-level factors contributing to lung nodule management disparities, there was consensus among the committee about the importance of defining these factors, determining the optimal research approaches to document them, and evaluating the best methods for measuring the influence of these factors on disparities in lung nodule evaluation.</p><p>The committee reviewed the importance of identifying direct and indirect mediators of health disparities related to lung nodule evaluation. Causal inference is particularly challenging in this setting given that randomization cannot be used except when evaluating interventions to mitigate disparities in care. However, observational data may be prone to confounding and other biases (<xref rid="bib44" ref-type="bibr">44</xref>), particularly without sufficiently large sample sizes, prospective data collection with standardized measures, and adequate retention. Therefore, rigorous methodology to study health disparities is warranted, including consistently specifying the underlying causal models being tested, precisely stating the study hypotheses, and more accurately describing the population being investigated. Advances in scientific, statistical, and epidemiologic inference (<xref rid="bib44" ref-type="bibr">44</xref>), such as causal models with directed acyclic graphs or cluster randomization, may be of particular utility to researchers. Use of these approaches in studying health disparities might be particularly advantageous by enabling the identification of key mediators of the disparities and enabling targeted interventions. This approach may also facilitate a more judicious allocation of limited healthcare resources to interventions likely to have a large impact.</p><p>The committee also discussed the information infrastructure required to carry out high-quality national disparities research. There was a consensus that the existing information infrastructure is insufficient, most notably because of fractured and inaccessible data across systems, making larger scale studies difficult. Improvements to the information infrastructure, including electronic health records (EHRs) and standardized measures of SDOH and other factors, will be required if more meaningful research on health disparities related to lung nodule management is conducted.</p><p>Finally, the committee discussed the potential impact of patient values and preferences on assessing lung nodule management disparities and effective communication about risks and benefits. Although there was a consensus that it would be important to account for patient preferences and cultural values, the optimal approach to achieve this is unclear. Thus, additional studies are needed in this area.</p></sec><sec><title>Prioritization of research questions</title><p>Voting results indicated that committee members highly ranked questions on defining and documenting specific disparities in lung nodule evaluation, including studies evaluating whether the disparities noted in lung cancer screening, diagnosis, and treatment outcomes similarly pertain to evaluation of lung nodules (average Likert score 6.6) (<xref rid="tbl2" ref-type="table">Table 2</xref>). Committee members also highly ranked questions related to identifying the strategies necessary to document and measure factors contributing to disparities in lung nodule management (average Likert score 6.0) (<xref rid="tbl2" ref-type="table">Table 2</xref>).</p></sec></sec><sec><title>Patient-Level Interventions</title><sec><title>Summary of the evidence and knowledge gaps</title><p>Various factors at the patient level may influence the completion of lung nodule follow-up testing, including SDOH (<xref rid="bib45" ref-type="bibr">45</xref>&#8211;<xref rid="bib47" ref-type="bibr">47</xref>), cultural beliefs and attitudes (<xref rid="bib48" ref-type="bibr">48</xref>), health literacy and numeracy (<xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref>), English language proficiency (<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>), ease of accessing and affording medical care and follow-up imaging (<xref rid="bib53" ref-type="bibr">53</xref>&#8211;<xref rid="bib55" ref-type="bibr">55</xref>), and ability to navigate the health system (<xref rid="bib56" ref-type="bibr">56</xref>&#8211;<xref rid="bib61" ref-type="bibr">61</xref>). However, very few studies have examined whether interventions to address patient-level factors improve disparities in lung nodule evaluation.</p><p>SDOH include the socioeconomic factors that influence health (such as household income, educational attainment, and employment), other individual determinants including demographics, and structural determinants such as the physical environment, access to health care, and economic opportunity. Studies of SDOH have shown that residence in disadvantaged neighborhoods is associated with higher incidence of lung cancer (<xref rid="bib45" ref-type="bibr">45</xref>) and that public insurance or uninsured status and lower income are linked to lower rates of resection (including use of minimally invasive surgery), increased risk for postoperative mortality, and lower long-term survival in localized-stage lung cancer (<xref rid="bib46" ref-type="bibr">46</xref>). Moreover, structural racism may underlie disparities in lung cancer screening. Black race was associated with lower rates of low-dose CT screening in neighborhoods where Black residents were historically denied home loans (redlining) (<xref rid="bib47" ref-type="bibr">47</xref>). Additional studies are needed to evaluate how SDOH contribute to lung nodule evaluation disparities and which interventions could improve outcomes.</p><p>Health literacy is also an important determinant of healthcare access and guideline-concordant care. Many minoritized patient groups have low literacy and numeracy, hindering their ability to assess the risk of lung cancer for a newly detected lung nodule or the potential risk/benefit ratio of the recommended workup. Prior research has demonstrated that language barriers are associated with difficulty navigating health systems and disparities in care (<xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref>). However, there is a paucity of studies evaluating whether language and communication barriers contribute to disparities in lung nodule evaluation and which interventions may effectively address these factors. In the context of smoking cessation, culturally tailored counseling programs for patients with limited English proficiency can increase abstinence rates (<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>). Although there is limited research specific to disparities in the evaluation of lung nodules, limited English proficiency, stigma related to lack of English proficiency, or inadequate cultural sensitivity may explain some of the gaps in care for Latino/a patients and other minoritized populations, such as recent immigrants.</p><p>Racial and ethnic health disparities in several chronic conditions are well established, including obesity (<xref rid="bib62" ref-type="bibr">62</xref>), diabetes (<xref rid="bib44" ref-type="bibr">44</xref>), hypertension (<xref rid="bib63" ref-type="bibr">63</xref>), cardiovascular disease (<xref rid="bib64" ref-type="bibr">64</xref>), and chronic kidney disease (<xref rid="bib65" ref-type="bibr">65</xref>), and these factors may worsen disparities in lung nodule evaluation. Although the mechanisms underlying these associations are unclear, potential mediators include prioritization of the discussion of lung nodule evaluation in the context of competing medical priorities, frequency of interaction with the healthcare system, the impact of comorbidities on survival that may influence the appropriateness of ongoing lung nodule evaluation, and potential limitations in patient functional status related to comorbidities that make it more difficult to attend lung nodule follow-up appointments (<xref rid="bib66" ref-type="bibr">66</xref>). Indeed, comorbidities may contribute to endometrial and breast cancer mortality (<xref rid="bib67" ref-type="bibr">67</xref>, <xref rid="bib68" ref-type="bibr">68</xref>), and higher comorbidity is associated with lower rates of guideline-concordant care for breast cancer. Moreover, patients with multiple comorbidities are less likely to be included in clinical trials (<xref rid="bib69" ref-type="bibr">69</xref>). Patients with severe mental illness including schizophrenia more likely to experience delays in diagnosis and treatment for lung cancer, and individuals with HIV infection are less frequently treated for lung cancer than HIV-uninfected counterparts (<xref rid="bib70" ref-type="bibr">70</xref>). Older individuals are less likely to receive guideline-concordant treatment for lung cancer (<xref rid="bib71" ref-type="bibr">71</xref>), raising the possibility that comorbidities may mediate this association given the higher occurrence of comorbidities in these patient groups (<xref rid="bib72" ref-type="bibr">72</xref>). People at increased risk for lung cancer have higher tobacco-related comorbidities, including chronic obstructive pulmonary disease (<xref rid="bib72" ref-type="bibr">72</xref>), highlighting the importance of accounting for comorbidities when evaluating disparities in lung nodule evaluation. In particular, researchers should consider accounting for comorbidities that significantly affect survival, affect functional status, or are related to cigarette smoking and may influence the risk of lung cancer.</p><p>Patient navigation, defined as the use of trained personnel to guide patients through their medical care, could help address patient-level factors contributing to disparities in lung nodule management. Navigators or community health workers familiar with cultural values of minoritized groups and community resources can bridge communication gaps and assist patients through complex health systems (<xref rid="bib56" ref-type="bibr">56</xref>). Patient navigation in urban, minoritized, and low-income populations has been shown to improve mammography completion for breast cancer screening, follow-up for abnormal mammography results (<xref rid="bib57" ref-type="bibr">57</xref>&#8211;<xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib73" ref-type="bibr">73</xref>), and breast cancer survival (<xref rid="bib57" ref-type="bibr">57</xref>). Among patients undergoing breast, cervical, colorectal, or prostate cancer screening, patient navigation improves time to diagnostic resolution and treatment initiation (<xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib74" ref-type="bibr">74</xref>), with the most significant benefit at centers with greater delays in follow-up (<xref rid="bib60" ref-type="bibr">60</xref>). For incidental lung nodules, an administrative navigator within the health system who contacted clinicians of patients flagged as lacking imaging follow-up improved the completion of lung nodule surveillance (<xref rid="bib61" ref-type="bibr">61</xref>). These findings warrant further study, as they suggest that patient navigation may mitigate disparities in lung nodule evaluation by improving follow-up for patients at the highest risk for delays.</p><p>Appointment-level interventions can be targeted to improve healthcare access or completion of recommended care. Interventions such as telehealth and e-consults to assess lung nodule risk offer opportunities to address geographic barriers to lung nodule evaluation but have not been systematically studied. Telehealth has emerged as a pragmatic approach to providing quality health services to diverse populations (<xref rid="bib75" ref-type="bibr">75</xref>) and may have particular utility for rural and geographically isolated populations (<xref rid="bib76" ref-type="bibr">76</xref>). However, telemedicine alternatives have not been studied in the context of lung nodule evaluation. Targeted telephone navigation for patients at highest risk for appointment no-shows effectively improved attendance to cancer care clinic appointments (<xref rid="bib77" ref-type="bibr">77</xref>). However, minoritized groups, low-income populations, and older adults may have limited access to digital communication technologies, generating concerns that appointment-level interventions dependent on these systems may aggravate care disparities. In addition, these interventions, including the optimal intensity and method of reminders, have not been systematically evaluated in the context of lung nodule evaluation.</p><p>Appointment reminders are a pragmatic intervention used in cancer screening but have not been systematically studied in lung nodule evaluation. However, studies of tailored mammography reminders to patients (including written letters and phone calls) have yielded conflicting results for breast cancer screening of Black women in the United States (<xref rid="bib78" ref-type="bibr">78</xref>, <xref rid="bib79" ref-type="bibr">79</xref>). In Australia&#8217;s culturally and linguistically diverse patient groups, translated and culturally tailored phone reminders increased screening mammography scheduling rates, whereas written letters did not (<xref rid="bib80" ref-type="bibr">80</xref>). Given that language and health literacy barriers are associated with care gaps (<xref rid="bib50" ref-type="bibr">50</xref>), additional studies are needed to determine whether summaries tailored to patients with low literacy or limited English proficiency are more effective.</p></sec><sec><title>Prioritization of research questions</title><p>Committee members scored highly on questions defining how SDOH influence disparities in lung nodule evaluation and evaluating the impact of appointment-level interventions, patient navigation, and strategies to address communication and language barriers. Questions related to defining how SDOH affect disparities in lung nodule evaluation were ranked most highly (average Likert score 6.3, average rank 2.9). This was followed by questions related to the effectiveness of appointment-level interventions and evaluation of how their effectiveness varies across different practice settings (average Likert score 6.3, average rank 3.1), questions related to the impact of patient navigation (average Likert score 6.3, average rank 3.4), and questions related to the optimal approach to addressing communication and language barriers (average Likert score 6.3, average rank 4.1) (<xref rid="tbl2" ref-type="table">Table 2</xref>). The committee noted that without first defining the impact of comorbidities on disparities in lung nodule evaluation, there would be a high probability of confounding, as the comorbidities would be associated with the exposure and outcome of interest.</p></sec></sec><sec><title>Interventions at the Clinician Level</title><sec><title>Summary of the evidence and knowledge gaps</title><p>Clinician recommendations to patients are a critical intermediate step to increasing appropriate follow-up for lung nodules. Yet there has been little research on clinician-level factors and even fewer studies on interventions to improve lung nodule evaluation. In addition, several factors may influence clinical recommendations for lung nodule follow-up, including patient&#8211;clinician communication, clinician demographic characteristics, and other factors such as years of training, implicit biases, and cultural stereotypes.</p><p>Patient&#8211;clinician communication may contribute to disparities in managing nodules, as these interactions influence patients&#8217; understanding of the recommended testing and the importance of follow-up. However, there is a lack of research examining this question, given that communication is not well reflected in the EHR and that patients may not accurately recall and/or report their clinical interactions. In addition, it is challenging and costly to record, transcribe, and code patient&#8211;clinician interactions to directly analyze the quality of communication. Prior studies have shown that patient&#8211;clinician communication influences patients&#8217; perceptions of lung nodules and related distress (<xref rid="bib81" ref-type="bibr">81</xref>). A survey study showed that patients with lung cancer who perceived communication with their clinicians as warm and friendly and reported receiving high-quality information about lung cancer management were more likely to undergo treatment (<xref rid="bib82" ref-type="bibr">82</xref>). In this study, other communication domains, such as physician support and patient symptoms or needs, were not independent predictors of treatment (<xref rid="bib82" ref-type="bibr">82</xref>). Oral communication rather than communication by letter was preferred by patients in a qualitative study evaluating communication about lung cancer screening results (<xref rid="bib83" ref-type="bibr">83</xref>). However, communication preferences were not stratified by race or ethnicity. Specific strategies to reduce disparities by improving patient&#8211;clinician communication, such as closed-loop and written versus oral communication, have not been examined in lung nodule management.</p><p>Racial or ethnic concordance between patients and their healthcare providers is associated with higher patient experience scores (<xref rid="bib84" ref-type="bibr">84</xref>). It is unclear whether and how clinician characteristics such as gender, race, ethnicity, years of education, specialty, years since completion of training, or practice setting affect disparities in lung nodule evaluation. The committee acknowledged that practice setting might affect access to diagnostic procedures, diagnostic biomarker testing, and expert review and input regarding management.</p><p>Little is known about the role of implicit bias or stereotypes in disparities in lung nodule evaluation. In lung cancer screening, women may be less likely than men to have discussed lung cancer screening with their clinicians (<xref rid="bib85" ref-type="bibr">85</xref>), suggesting an implicit gender bias. In mammography screening for breast cancer, in which abnormal imaging results are common, and false-positive results are common, perceived discrimination was associated with significant diagnostic delays (<xref rid="bib86" ref-type="bibr">86</xref>). Studies on patients with advanced cancer showed that higher degrees of oncologist implicit racial bias were associated with shorter patient interactions, less patient-centered and supportive communication, and more patient difficulty remembering the contents of the interaction (<xref rid="bib87" ref-type="bibr">87</xref>). In primary care, physicians&#8217; implicit racial bias was associated with more frequent use of first-person pronouns, which may suggest a sense of social dominance, and anxiety-related words such as &#8220;worry&#8221; and &#8220;nervous,&#8221; which highlights the potential role of anxiety in racially discordant interactions (<xref rid="bib88" ref-type="bibr">88</xref>). Studies of the impact of implicit bias and linguistic patterns, reducing implicit bias, or implementing cultural sensitivity training on reducing disparities in lung nodule evaluation are needed.</p></sec><sec><title>Prioritization of research questions</title><p>Committee members ranked questions on patient&#8211;clinician communication and the role of implicit bias very highly. Questions related to interventions to improve patient&#8211;clinician communication to reduce disparities in lung nodule evaluation and increase the quality of information transmission and retention were highly prioritized with slight variation (average Likert score 6.6). Questions on how implicit bias may affect communication, time spent with patients, and completion of lung nodule follow-up were ranked second on average (average Likert score 6.0). The committee noted that concerns about the feasibility of investigating implicit bias and its effect on disparities in lung nodule evaluation and patient outcomes were a factor in the rankings (<xref rid="tbl2" ref-type="table">Table 2</xref>). The committee also acknowledged that interventions targeting clinician-level factors would require concomitant delivery with system-focused interventions such as EHR reminders and inclusion of non-physician clinical care team members (e.g., nurse coordinators, patient service representatives, medical assistants) that provide initial face-to-face contact with patients.</p></sec></sec><sec><title>Interventions at the Level of the Health System</title><sec><title>Summary of the evidence and knowledge gaps</title><p>A mismatch between patient needs and health system resources may contribute to disparities in lung nodule management. This section summarizes knowledge gaps and evidence for interventions that address access to health care, information technology resources, and programmatic structure that may affect disparities in lung nodule evaluation.</p><sec><title>
<sc>Access to health care</sc>
</title><p>Lack of adequate health insurance affects people of all racial and ethnic backgrounds and individuals living in rural areas (<xref rid="bib53" ref-type="bibr">53</xref>). Before the Patient Protection and Affordable Care Act was implemented, half the U.S. population could not afford recommended care, including cancer screening (<xref rid="bib53" ref-type="bibr">53</xref>). Moreover, even relatively small copayments decreased screening mammography rates (<xref rid="bib54" ref-type="bibr">54</xref>). Inequities in resource availability and allocation within health systems primarily serving non-Hispanic White patients may further exacerbate disparities in care (<xref rid="bib55" ref-type="bibr">55</xref>). These inequities may be worsened during health emergencies constraining resources such as the coronavirus disease (COVID-19) pandemic (<xref rid="bib89" ref-type="bibr">89</xref>).</p><p>Patients evaluated in the emergency department may or may not have primary care physicians documented for communication of incidental findings such as lung nodules. Although there are no studies evaluating lung nodule follow-up rates stratified by whether the patient has a primary care provider (PCP) documented in the EHR, many radiology notification systems and interventions rely on communicating the result with a patient&#8217;s PCP or ordering clinician (<xref rid="bib90" ref-type="bibr">90</xref>). However, one in four patients in the United States does not have a PCP, and minoritized groups and patients without insurance are less likely to have a regular source of care (<xref rid="bib91" ref-type="bibr">91</xref>). In addition, new patients in a health system (e.g., those undergoing CT scans in emergency departments) may not have PCPs listed in the EHR (<xref rid="bib90" ref-type="bibr">90</xref>). These factors may further exacerbate disparities in lung nodule evaluation.</p><p>Factors such as residential segregation, geographic distance to healthcare facilities, and access to transportation also contribute to health disparities (<xref rid="bib76" ref-type="bibr">76</xref>, <xref rid="bib92" ref-type="bibr">92</xref>). There are significant knowledge gaps in this area related to lung nodule management. In the context of lung cancer screening, access to programs and follow-up care has significant geographic variability. Rural residents are less likely to have access to a lung cancer screening center within 30 miles or a 30-minute drive (<xref rid="bib93" ref-type="bibr">93</xref>). Geospatial cluster analysis showed that the distribution of comprehensive lung cancer screening programs was lowest in the southeastern United States, with the highest lung cancer burden (<xref rid="bib28" ref-type="bibr">28</xref>). Even in urban areas, where screening programs are more tightly clustered, individuals of low socioeconomic status are less likely to undergo screening despite a higher risk of lung cancer (<xref rid="bib94" ref-type="bibr">94</xref>). Disparities between the number of individuals at increased risk for lung cancer and the availability of accredited lung cancer screening programs in geographic regions suggest similar disparities for lung nodule evaluation and highlight the risk that access to subspecialty care and specialized diagnostic procedures, such as transthoracic needle biopsy or bronchoscopy, may be similarly limited.</p><p>Various approaches may reduce disparities in lung nodule management because of geographic barriers and access to care. For example, telehealth and e-consults can bring quality health services to rural and other underresourced clinical settings, including remote interpretation of CT scans by qualified radiologists to help maintain lung nodule reporting consistency. Multidisciplinary telehealth consultative services might also broaden evaluation options for geographically isolated patients and facilitate shared decision making in lung cancer screening (<xref rid="bib95" ref-type="bibr">95</xref>). Another approach to reducing geographic barriers to obtaining follow-up imaging is mobile CT units (<xref rid="bib76" ref-type="bibr">76</xref>). For example, the Manchester Lung Health Check program provided lung cancer screening to low-income communities, achieving high uptake and 90% adherence to annual follow-up among eligible individuals (<xref rid="bib96" ref-type="bibr">96</xref>). In addition, 75% of individuals screened through this program indicated that location was essential to their choice to be screened, and 23% reported that they would be less likely to seek out screening in a hospital-based program (<xref rid="bib96" ref-type="bibr">96</xref>).</p></sec><sec><title>
<sc>Information technology resources</sc>
</title><p>In the context of lung cancer screening, appropriate tracking and management of abnormal low-dose CT scan findings, including lung nodules, has been identified as a significant challenge at federally qualified health centers (<xref rid="bib97" ref-type="bibr">97</xref>). Investment in information technology resources, such as lung nodule tracking software, can facilitate abnormal result follow-up (<xref rid="bib98" ref-type="bibr">98</xref>). Other approaches to improving incidental lung nodule tracking and follow-up have included multidisciplinary teams tasked with reviewing CT examinations and notifying the ordering clinician and the patient (<xref rid="bib61" ref-type="bibr">61</xref>), automated processing (e.g., natural language processing) of free-text CT reports (<xref rid="bib90" ref-type="bibr">90</xref>), computerized registries (<xref rid="bib99" ref-type="bibr">99</xref>), and use of standardized templates for reporting lung nodule results and recommendations (<xref rid="bib100" ref-type="bibr">100</xref>). However, the optimal strategies to implement technologies to improve management of lung nodules are unclear. In addition, whether improved tracking reduces disparities in lung nodule evaluation is unknown.</p><p>There has been little research on resource allocation strategies for lung nodule management. One approach would entail measuring and quantifying the cost-effectiveness and value-added for infrastructure and personnel. Using machine learning or the EHR, a complementary approach might use automated or semiautomated resource allocation strategies to identify individuals at highest risk for loss to follow-up. For example, one study evaluating factors predictive of lung nodule follow-up demonstrated that a combination of physician&#8211;patient communication variables (e.g., whether and how the finding was communicated), patient variables (e.g., demographics), and radiology report variables (e.g., nodule size, whether follow-up recommendations were given) were significant predictors of patient follow-up for lung nodule evaluation (<xref rid="bib101" ref-type="bibr">101</xref>). This observation suggests that data analytic approaches can optimize lung nodule follow-up and have potential utility for allocating resources to patients at highest risk for delayed workup. Alternatively, system-level interventions such as the implementation of physician reminders, direct outreach to patients in need of follow-up, and audit feedback might improve disparities in lung nodule management. This approach has effectively improved breast, cervical, and colorectal cancer screening (<xref rid="bib102" ref-type="bibr">102</xref>) and reduced racial disparities in lung cancer treatment (<xref rid="bib103" ref-type="bibr">103</xref>).</p><p>The panel reached a consensus about the importance of literacy matched educational content and communication about lung nodules found on CT and their required follow-up in reducing disparities in lung nodule management. However, the optimal approach to achieving this important goal is unknown. For example, it is unclear whether system-level interventions such as written after-visit summaries and automated reminders improve lung nodule management in patients with low literacy. In addition, compared with in-person notifications, phone calls or letters about mammography results can lead to diagnostic delays and an incomplete understanding of mammography results (<xref rid="bib86" ref-type="bibr">86</xref>). It is unclear whether the method of communication of lung nodule follow-up recommendations affects disparities in care.</p></sec><sec><title>
<sc>Program structure</sc>
</title><p>The role of centralized lung nodule management protocols, as opposed to decentralized approaches that rely solely on the ordering or primary care clinician, may be of particular relevance to patients who receive diagnoses of incidental pulmonary nodules in the context of emergency department visits. Studies have shown greater adherence to annual lung cancer screening in centralized screening programs, and improved disparities in follow-up rates for Black individuals (<xref rid="bib10" ref-type="bibr">10</xref>). The impact of centralized versus decentralized lung nodule follow-up programs on disparities in lung nodule evaluation is not known.</p><p>Variability in radiology reporting of CT findings, including vague language (<xref rid="bib104" ref-type="bibr">104</xref>, <xref rid="bib105" ref-type="bibr">105</xref>) and lack of inclusion of the finding in the final impression of the report, has been associated with decreased completion of lung nodule follow-up recommendations (<xref rid="bib106" ref-type="bibr">106</xref>). Prior studies have shown that follow-up recommendations can vary if an individual&#8217;s risk factors for lung cancer are unknown to the radiologist (<xref rid="bib90" ref-type="bibr">90</xref>). The complexity of Fleischner Society guidelines for incidental lung nodule management (<xref rid="bib107" ref-type="bibr">107</xref>), which incorporate multiple clinical and radiographic risks, may be an additional barrier to lung nodule tracking and standardization of recommendations. A standardized lexicon may decrease variability in radiology reports, but it is unclear if this would reduce disparities in lung nodule management.</p></sec></sec><sec><title>Prioritization of research questions</title><p>Questions related to specific interventions, such as patient navigators or culturally trained multidisciplinary teams, to improve lung nodule evaluation were ranked most highly (average Likert score 6.3). This was followed by questions related to resource allocation strategies and methods for tracking lung nodule follow-up (average Likert score 6.2); questions about the use of machine learning, algorithms, and the EHR to allocate resources to patients at highest risk for lack of or delayed follow-up to lung nodule follow-up (average Likert score 6.2); and questions on the management of patients with incidental lung nodules detected during emergency department or inpatient visits (average Likert score 6.2) (<xref rid="tbl2" ref-type="table">Table 2</xref>).</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our committee identified significant gaps in knowledge regarding interventions to address disparities in lung nodule evaluation. There is currently no standardized approach to identifying factors associated with lung nodule management disparities and a limited understanding of the factors that mediate these associations. Furthermore, there are few data evaluating the role of SDOH, limited health literacy and numeracy, or coexisting medical conditions on disparities in lung nodule management. The optimal approaches to addressing these barriers also remain unclear. The optimal strategy to improve patient&#8211;clinician communication and information transmission and/or retention is unknown, as is the impact of culturally enriched multidisciplinary teams.</p><p>Using a formal consensus development process, the committee identified several areas in which further research would significantly affect decision making regarding resources and strategies to address disparities in lung nodule management. Regarding research methodology, committee members gave highest ratings to questions better defining the disparities in lung nodule management. Within the patient domain, research questions related to how SDOH influence lung nodule evaluation and affect clinician interactions were rated most highly. For the clinician domain, the need for studies to evaluate strategies to improve patient&#8211;clinician communication to reduce disparities in lung nodule evaluation was ranked highest. Finally, in the health systems domain, committee members indicated that research on the effectiveness of specific interventions such as patient navigators and culturally trained multidisciplinary teams in reducing disparities in lung nodule management was the highest priority.</p><p>This research statement establishes a framework for guiding future studies to address knowledge gaps in lung nodule evaluation and a roadmap for governmental and nongovernmental funding agencies to generate high-priority and high-quality research related to interventions addressing disparities in lung nodule management.</p></sec></body><back><ack><sec><title>Acknowledgment</title><p>The authors thank Kimberly Lawrence and John Harmon of the ATS for their help in supporting the meetings and survey administration to develop this research statement.</p><p>This official research statement was prepared by an <italic toggle="yes">ad hoc</italic> subcommittee on interventions to mitigate disparities in lung nodule evaluation of the ATS Assembly on Thoracic Oncology.</p><p>
<bold>Members of the subcommittee are as follows:</bold>
</p><p>K<sc>atrina</sc> S<sc>teiling</sc>, M.D., M.S<sc>c</sc>. (<italic toggle="yes">Chair</italic>)<sup>1</sup>*<sup>&#8225;</sup></p><p>J<sc>uan</sc> W<sc>isnivesky</sc>, M.D., Dr.P.H. (<italic toggle="yes">Co-Chair</italic>)<sup>2&#8225;&#167;</sup></p><p>A<sc>bbie</sc> B<sc>egnaud</sc>, M.D.<sup>3&#449;</sup></p><p>J<sc>uan</sc> C. C<sc>eled&#243;n</sc>, M.D., Dr.P.H.<sup>4&#167;</sup></p><p>M<sc>arjory</sc> C<sc>harlot</sc>, M.D., M.P.H., M.S<sc>c</sc>.<sup>5&#449;</sup></p><p>F<sc>rank</sc> D<sc>ietrick</sc>, B.A.<sup>&#449;</sup></p><p>N<sc>arjust</sc> D<sc>uma</sc>, M.D.<sup>6</sup>*</p><p>C<sc>hidiebere</sc> P<sc>eter</sc> E<sc>chieh</sc>, M.B. B.Ch., F.W.A.C.S.<sup>7&#8225;&#167;</sup></p><p>K<sc>wun</sc> M. F<sc>ong</sc>, M.B. B.S., P<sc>h</sc>.D.<sup>8,9&#167;</sup></p><p>J<sc>ean</sc> G. F<sc>ord</sc>, M.D.*</p><p>M<sc>ichael</sc> K. G<sc>ould</sc>, M.D., M.S.<sup>10&#167;</sup></p><p>F<sc>ernando</sc> H<sc>olguin</sc>, M.D.<sup>11</sup>*</p><p>H<sc>asmeena</sc> K<sc>athuria</sc>, M.D.<sup>1&#8225;&#449;</sup></p><p>D<sc>avid</sc> E. O<sc>st</sc>, M.D., M.P.H.<sup>12&#8225;&#182;</sup></p><p>E<sc>liseo</sc> J. P&#233;<sc>rez</sc>-S<sc>table</sc>, M.D.<sup>13&#167;</sup></p><p>M. P<sc>atricia</sc> R<sc>ivera</sc>, M.D.<sup>14&#8225;</sup>**</p><p>N<sc>ichole</sc> T. T<sc>anner</sc>, M.D., M.S.C.R.<sup>15,16&#8225;&#8225;</sup></p><p>C<sc>arey</sc> C<sc>onley</sc> T<sc>homson</sc>, M.D., M.P.H.<sup>17,18&#167;</sup></p><p>R<sc>enda</sc> S<sc>oylemez</sc> W<sc>iener</sc>, M.D., M.P.H.<sup>1,19&#167;</sup></p><p><sup>1</sup>Chobanian &amp; Avedisian School of Medicine, Boston University, Boston, Massachusetts; <sup>2</sup>Icahn School of Medicine at Mount Sinai, New York, New York; <sup>3</sup>University of Minnesota, Minneapolis, Minnesota; <sup>4</sup>University of Pittsburgh, Pittsburgh, Pennsylvania; <sup>5</sup>Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; <sup>6</sup>Dana-Farber Cancer Institute, Boston, Massachusetts; <sup>7</sup>University of Calabar Teaching Hospital, Calabar, Nigeria; <sup>8</sup>The Prince Charles Hospital, Brisbane, Queensland, Australia; <sup>9</sup>University of Queensland Thoracic Research Centre, Brisbane, Queensland, Australia; <sup>10</sup>Bernard J. Tyson School of Medicine, Kaiser Permanente, Pasadena, California; <sup>11</sup>School of Medicine, University of Colorado, Aurora, Colorado; <sup>12</sup>MD Anderson Cancer Center, Houston, Texas; <sup>13</sup>NIH, Bethesda, Maryland; <sup>14</sup>University of Rochester Medical Center, Rochester, New York; <sup>15</sup>Medical University of South Carolina, Charleston, South Carolina; <sup>16</sup>Ralph H. Johnson VA Medical Center, Charleston, South Carolina; <sup>17</sup>Mount Auburn Hospital, Cambridge, Massachusetts; <sup>18</sup>Harvard Medical School, Boston, Massachusetts; and <sup>19</sup>VA Boston Healthcare System, Boston, Massachusetts</p><p>*Member, clinician workgroup.</p><p><sup>&#8225;</sup>Writing committee.</p><p><sup>&#167;</sup>Member, health systems workgroup.</p><p><sup>&#449;</sup>Member, patient workgroup.</p><p><sup>&#182;</sup>Moderator, patient workgroup.</p><p>**Moderator, health systems workgroup.</p><p><sup>&#8225;&#8225;</sup>Moderator, clinician workgroup.</p></sec></ack><fn-group><fn><p>T<sc>his official</sc> R<sc>esearch</sc> S<sc>tatement of the</sc> A<sc>merican</sc> T<sc>horacic</sc> S<sc>ociety was approved</sc> O<sc>ctober</sc> 2022</p></fn><fn fn-type="supported-by"><p>Supported by the American Thoracic Society.</p></fn><fn><p>An Executive Summary of this document is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.atsjournals.org/doi/suppl/10.1164/rccm.202212-2216ST" ext-link-type="uri">https://www.atsjournals.org/doi/suppl/10.1164/rccm.202212-2216ST</ext-link>.</p></fn><fn><p>DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1164/rccm.202212-2216ST" ext-link-type="uri">10.1164/rccm.202212-2216ST</ext-link></p></fn><fn><p><bold>Subcommittee Disclosures:</bold> K.S. served on editorial board for BMC Genomics; served as consultant for CRICO; holds US Patent 9677138 and pending Provisional Patent 62916431; received royalties from UpToDate. J.C. received research support from GlaxoSmithKline, Merck, and Pharmavite. N.D. served on advisory committee for AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Inivata, Janssen, Merck, Neogenomics, Novartis, Pfizer; served as consultant for AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Janssen, Merck, Neogenomics, Novartis. K.F. served as consultant for Cochrane Clinical Answers; served as president of Asia Pacific Society of Respirology; received research support from Medical Research Future Fund (Emerging Priorities and Consumer Driven Research Initiative), MeVis Veolity, National Health and Medical Research Council, and Olympus; received royalties from UpToDate and Cochrane Clinical Answers; received travel support from World Conference on Lung Cancer. J.G.F. served on advisory committee for President&#8217;s Cancer Panel; received research support from Medial EarlySign; received royalties from UpToDate. H.K. served as consultant and received royalties from UpToDate. D.E.O. served as consultant for ABIM, Beckton Dickensen, and Intuitive; received research support from Intuitive. N.T. served on advisory committee for CHEST; served as consultant for Nucleix, Oncimmune, and Oncocyte; served as a speaker at Cleveland Clinic Biomarker Summit; received research support from Biodesix, Delfi, Eon, Exact Sciences, Nucleix, Oncocyte, and SEER. C.C.T. served on advisory committee for American College Radiology, Healthmyne, and Median Technology; served as consultant for Fulcrum and Median Technology; received royalties from UpToDate; served as speaker American Lung Association and National Lunch Cancer Roundtable. R.W. served on advisory committee for American College of Chest Physicians and National Lung Cancer Round Table; received research support from NIH, PCORI, and VA HSR&amp;D. J.W. served as consultant for Atea Pharmaceutical, Banook, GlaxoSmithKline. K.I.A., A.B., M.C., F.D., C.P.E., M.G., F.H., E.J.P.S., M.P.R. reported no commercial or relevant non-commercial interests from ineligible companies.</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gould</surname><given-names>MK</given-names></name><name name-style="western"><surname>Tang</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ILA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Danforth</surname><given-names>KN</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Recent trends in the identification of incidental pulmonary nodules</article-title><source><italic toggle="yes">Am J Respir Crit Care Med</italic></source><year>2015</year><volume>192</volume><fpage>1208</fpage><lpage>1214</lpage><pub-id pub-id-type="pmid">26214244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201505-0990OC</pub-id></mixed-citation></ref><ref id="bib2"><label>2.</label><mixed-citation publication-type="other"><collab>American College of Radiology</collab><year>2022</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads" ext-link-type="uri">https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads</ext-link></mixed-citation></ref><ref id="bib3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2019</article-title><source><italic toggle="yes">CA Cancer J Clin</italic></source><year>2019</year><volume>69</volume><fpage>7</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">30620402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21551</pub-id></mixed-citation></ref><ref id="bib4"><label>4.</label><mixed-citation publication-type="other"><collab>American Cancer Society</collab><year>2020</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html" ext-link-type="uri">https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html</ext-link></mixed-citation></ref><ref id="bib5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source><italic toggle="yes">CA Cancer J Clin</italic></source><year>2021</year><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">33538338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21660</pub-id></mixed-citation></ref><ref id="bib6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldstraw</surname><given-names>P</given-names></name><name name-style="western"><surname>Chansky</surname><given-names>K</given-names></name><name name-style="western"><surname>Crowley</surname><given-names>J</given-names></name><name name-style="western"><surname>Rami-Porta</surname><given-names>R</given-names></name><name name-style="western"><surname>Asamura</surname><given-names>H</given-names></name><name name-style="western"><surname>Eberhardt</surname><given-names>WEE</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions</collab></person-group><collab>International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions</collab><article-title>The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer</article-title><source><italic toggle="yes">J Thorac Oncol</italic></source><year>2016</year><volume>11</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">26762738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtho.2015.09.009</pub-id></mixed-citation></ref><ref id="bib7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schut</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mortani Barbosa</surname><given-names>EJ</given-names><suffix>Jr</suffix></name></person-group><article-title>Racial/ethnic disparities in follow-up adherence for incidental pulmonary nodules: an application of a cascade-of-care framework</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2020</year><volume>17</volume><fpage>1410</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">32771492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2020.07.018</pub-id><pub-id pub-id-type="pmcid">PMC7655670</pub-id></mixed-citation></ref><ref id="bib8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iaccarino</surname><given-names>JM</given-names></name><name name-style="western"><surname>Steiling</surname><given-names>K</given-names></name><name name-style="western"><surname>Slatore</surname><given-names>CG</given-names></name><name name-style="western"><surname>Drainoni</surname><given-names>ML</given-names></name><name name-style="western"><surname>Wiener</surname><given-names>RS</given-names></name></person-group><article-title>Patient characteristics associated with adherence to pulmonary nodule guidelines</article-title><source><italic toggle="yes">Respir Med</italic></source><year>2020</year><volume>171</volume><fpage>106075</fpage><pub-id pub-id-type="pmid">32658836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.rmed.2020.106075</pub-id></mixed-citation></ref><ref id="bib9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N&#250;&#241;ez</surname><given-names>ER</given-names></name><name name-style="western"><surname>Caverly</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>ME</given-names></name><name name-style="western"><surname>Qian</surname><given-names>SX</given-names></name><name name-style="western"><surname>Boudreau</surname><given-names>JH</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Adherence to follow-up testing recommendations in US veterans screened for lung cancer, 2015&#8211;2019</article-title><source><italic toggle="yes">JAMA Netw Open</italic></source><year>2021</year><volume>4</volume><fpage>e2116233</fpage><pub-id pub-id-type="pmid">34236409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.16233</pub-id><pub-id pub-id-type="pmcid">PMC8267608</pub-id></mixed-citation></ref><ref id="bib10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>RY</given-names></name><name name-style="western"><surname>Rendle</surname><given-names>KA</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>N</given-names></name><name name-style="western"><surname>Saia</surname><given-names>CA</given-names></name><name name-style="western"><surname>Neslund-Dudas</surname><given-names>C</given-names></name><name name-style="western"><surname>Greenlee</surname><given-names>RT</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Racial disparities in adherence to annual lung cancer screening and recommended follow-up care: a multicenter cohort study</article-title><source><italic toggle="yes">Ann Am Thorac Soc</italic></source><year>2022</year><volume>19</volume><fpage>1561</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">35167781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.202111-1253OC</pub-id><pub-id pub-id-type="pmcid">PMC9447384</pub-id></mixed-citation></ref><ref id="bib11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kunitomo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bade</surname><given-names>B</given-names></name><name name-style="western"><surname>Gunderson</surname><given-names>CG</given-names></name><name name-style="western"><surname>Akg&#252;n</surname><given-names>KM</given-names></name><name name-style="western"><surname>Brackett</surname><given-names>A</given-names></name><name name-style="western"><surname>Cain</surname><given-names>H</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Racial differences in adherence to lung cancer screening follow-up: a systematic review and meta-analysis</article-title><source><italic toggle="yes">Chest</italic></source><year>2022</year><volume>161</volume><fpage>266</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">34390706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2021.07.2172</pub-id></mixed-citation></ref><ref id="bib12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lake</surname><given-names>M</given-names></name><name name-style="western"><surname>Shusted</surname><given-names>CS</given-names></name><name name-style="western"><surname>Juon</surname><given-names>HS</given-names></name><name name-style="western"><surname>McIntire</surname><given-names>RK</given-names></name><name name-style="western"><surname>Zeigler-Johnson</surname><given-names>C</given-names></name><name name-style="western"><surname>Evans</surname><given-names>NR</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up</article-title><source><italic toggle="yes">BMC Cancer</italic></source><year>2020</year><volume>20</volume><fpage>561</fpage><pub-id pub-id-type="pmid">32546140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-020-06923-0</pub-id><pub-id pub-id-type="pmcid">PMC7298866</pub-id></mixed-citation></ref><ref id="bib13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>R</given-names></name><name name-style="western"><surname>Ward</surname><given-names>E</given-names></name><name name-style="western"><surname>Brawley</surname><given-names>O</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths</article-title><source><italic toggle="yes">CA Cancer J Clin</italic></source><year>2011</year><volume>61</volume><fpage>212</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">21685461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.20121</pub-id></mixed-citation></ref><ref id="bib14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delva</surname><given-names>J</given-names></name><name name-style="western"><surname>Tellez</surname><given-names>M</given-names></name><name name-style="western"><surname>Finlayson</surname><given-names>TL</given-names></name><name name-style="western"><surname>Gretebeck</surname><given-names>KA</given-names></name><name name-style="western"><surname>Siefert</surname><given-names>K</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DR</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Cigarette smoking among low-income African Americans: a serious public health problem</article-title><source><italic toggle="yes">Am J Prev Med</italic></source><year>2005</year><volume>29</volume><fpage>218</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">16168872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2005.05.004</pub-id><pub-id pub-id-type="pmcid">PMC1817892</pub-id></mixed-citation></ref><ref id="bib15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aldrich</surname><given-names>MC</given-names></name><name name-style="western"><surname>Mercaldo</surname><given-names>SF</given-names></name><name name-style="western"><surname>Sandler</surname><given-names>KL</given-names></name><name name-style="western"><surname>Blot</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Grogan</surname><given-names>EL</given-names></name><name name-style="western"><surname>Blume</surname><given-names>JD</given-names></name></person-group><article-title>Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers</article-title><source><italic toggle="yes">JAMA Oncol</italic></source><year>2019</year><volume>5</volume><fpage>1318</fpage><lpage>1324</lpage><pub-id pub-id-type="pmid">31246249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2019.1402</pub-id><pub-id pub-id-type="pmcid">PMC6604090</pub-id></mixed-citation></ref><ref id="bib16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haiman</surname><given-names>CA</given-names></name><name name-style="western"><surname>Stram</surname><given-names>DO</given-names></name><name name-style="western"><surname>Wilkens</surname><given-names>LR</given-names></name><name name-style="western"><surname>Pike</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kolonel</surname><given-names>LN</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>BE</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Ethnic and racial differences in the smoking-related risk of lung cancer</article-title><source><italic toggle="yes">N Engl J Med</italic></source><year>2006</year><volume>354</volume><fpage>333</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">16436765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa033250</pub-id></mixed-citation></ref><ref id="bib17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stram</surname><given-names>DO</given-names></name><name name-style="western"><surname>Park</surname><given-names>SL</given-names></name><name name-style="western"><surname>Haiman</surname><given-names>CA</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>SE</given-names></name><name name-style="western"><surname>Patel</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hecht</surname><given-names>SS</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Racial/ethnic differences in lung cancer incidence in the Multiethnic Cohort Study: an update</article-title><source><italic toggle="yes">J Natl Cancer Inst</italic></source><year>2019</year><volume>111</volume><fpage>811</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">30698722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djy206</pub-id><pub-id pub-id-type="pmcid">PMC6695313</pub-id></mixed-citation></ref><ref id="bib18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Javid</surname><given-names>SH</given-names></name><name name-style="western"><surname>Varghese</surname><given-names>TK</given-names></name><name name-style="western"><surname>Morris</surname><given-names>AM</given-names></name><name name-style="western"><surname>Porter</surname><given-names>MP</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Buchwald</surname><given-names>D</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>Collaborative to Improve Native Cancer Outcomes (CINCO)</collab></person-group><article-title>Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients</article-title><source><italic toggle="yes">Cancer</italic></source><year>2014</year><volume>120</volume><fpage>2183</fpage><lpage>2190</lpage><pub-id pub-id-type="pmid">24711210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.28683</pub-id><pub-id pub-id-type="pmcid">PMC4219619</pub-id></mixed-citation></ref><ref id="bib19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balekian</surname><given-names>AA</given-names></name><name name-style="western"><surname>Wisnivesky</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gould</surname><given-names>MK</given-names></name></person-group><article-title>Surgical disparities among patients with stage I lung cancer in the National Lung Screening Trial</article-title><source><italic toggle="yes">Chest</italic></source><year>2019</year><volume>155</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">30056040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2018.07.011</pub-id></mixed-citation></ref><ref id="bib20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farjah</surname><given-names>F</given-names></name><name name-style="western"><surname>Wood</surname><given-names>DE</given-names></name><name name-style="western"><surname>Yanez</surname><given-names>ND</given-names></name><name name-style="western"><surname>Vaughan</surname><given-names>TL</given-names></name><name name-style="western"><surname>Symons</surname><given-names>RG</given-names></name><name name-style="western"><surname>Krishnadasan</surname><given-names>B</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Racial disparities among patients with lung cancer who were recommended operative therapy</article-title><source><italic toggle="yes">Arch Surg</italic></source><year>2009</year><volume>144</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">19153319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archsurg.2008.519</pub-id><pub-id pub-id-type="pmcid">PMC2688646</pub-id></mixed-citation></ref><ref id="bib21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisnivesky</surname><given-names>JP</given-names></name><name name-style="western"><surname>McGinn</surname><given-names>T</given-names></name><name name-style="western"><surname>Henschke</surname><given-names>C</given-names></name><name name-style="western"><surname>Hebert</surname><given-names>P</given-names></name><name name-style="western"><surname>Iannuzzi</surname><given-names>MC</given-names></name><name name-style="western"><surname>Halm</surname><given-names>EA</given-names></name></person-group><article-title>Ethnic disparities in the treatment of stage I non-small cell lung cancer</article-title><source><italic toggle="yes">Am J Respir Crit Care Med</italic></source><year>2005</year><volume>171</volume><fpage>1158</fpage><lpage>1163</lpage><pub-id pub-id-type="pmid">15735053</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200411-1475OC</pub-id></mixed-citation></ref><ref id="bib22"><label>22.</label><mixed-citation publication-type="other"><collab>National Cancer Institute</collab><year>2020</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://seer.cancer.gov/csr/1975_2016/index.html" ext-link-type="uri">https://seer.cancer.gov/csr/1975_2016/index.html</ext-link></mixed-citation></ref><ref id="bib23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>MC</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>MM</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>D</given-names></name><name name-style="western"><surname>Lally</surname><given-names>BE</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Do racial or socioeconomic disparities exist in lung cancer treatment?</article-title><source><italic toggle="yes">Cancer</italic></source><year>2010</year><volume>116</volume><fpage>2437</fpage><lpage>2447</lpage><pub-id pub-id-type="pmid">20209616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.24986</pub-id></mixed-citation></ref><ref id="bib24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hovanec</surname><given-names>J</given-names></name><name name-style="western"><surname>Siemiatycki</surname><given-names>J</given-names></name><name name-style="western"><surname>Conway</surname><given-names>DI</given-names></name><name name-style="western"><surname>Olsson</surname><given-names>A</given-names></name><name name-style="western"><surname>St&#252;cker</surname><given-names>I</given-names></name><name name-style="western"><surname>Guida</surname><given-names>F</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Lung cancer and socioeconomic status in a pooled analysis of case-control studies</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2018</year><volume>13</volume><fpage>e0192999</fpage><pub-id pub-id-type="pmid">29462211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0192999</pub-id><pub-id pub-id-type="pmcid">PMC5819792</pub-id></mixed-citation></ref><ref id="bib25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soneji</surname><given-names>S</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>NT</given-names></name><name name-style="western"><surname>Silvestri</surname><given-names>GA</given-names></name><name name-style="western"><surname>Lathan</surname><given-names>CS</given-names></name><name name-style="western"><surname>Black</surname><given-names>W</given-names></name></person-group><article-title>Racial and ethnic disparities in early-stage lung cancer survival</article-title><source><italic toggle="yes">Chest</italic></source><year>2017</year><volume>152</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">28450031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2017.03.059</pub-id><pub-id pub-id-type="pmcid">PMC5812758</pub-id></mixed-citation></ref><ref id="bib26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harvey</surname><given-names>G</given-names></name><name name-style="western"><surname>Kitson</surname><given-names>A</given-names></name></person-group><article-title>PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice</article-title><source><italic toggle="yes">Implement Sci</italic></source><year>2016</year><volume>11</volume><fpage>33</fpage><pub-id pub-id-type="pmid">27013464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13012-016-0398-2</pub-id><pub-id pub-id-type="pmcid">PMC4807546</pub-id></mixed-citation></ref><ref id="bib27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atkins</surname><given-names>GT</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T</given-names></name><name name-style="western"><surname>Munson</surname><given-names>J</given-names></name></person-group><article-title>Residence in rural areas of the United States and lung cancer mortality. Disease incidence, treatment disparities, and stage-specific survival</article-title><source><italic toggle="yes">Ann Am Thorac Soc</italic></source><year>2017</year><volume>14</volume><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">28118039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201606-469OC</pub-id></mixed-citation></ref><ref id="bib28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kale</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wisnivesky</surname><given-names>J</given-names></name><name name-style="western"><surname>Taioli</surname><given-names>E</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name></person-group><article-title>The landscape of US lung cancer screening services</article-title><source><italic toggle="yes">Chest</italic></source><year>2019</year><volume>155</volume><fpage>900</fpage><lpage>907</lpage><pub-id pub-id-type="pmid">30419236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2018.10.039</pub-id><pub-id pub-id-type="pmcid">PMC6533452</pub-id></mixed-citation></ref><ref id="bib29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steiling</surname><given-names>K</given-names></name><name name-style="western"><surname>Loui</surname><given-names>T</given-names></name><name name-style="western"><surname>Asokan</surname><given-names>S</given-names></name><name name-style="western"><surname>Nims</surname><given-names>S</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>P</given-names></name><name name-style="western"><surname>Rebello</surname><given-names>A</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Age, race, and income are associated with lower screening rates at a safety net hospital</article-title><source><italic toggle="yes">Ann Thorac Surg</italic></source><year>2020</year><volume>109</volume><fpage>1544</fpage><lpage>1550</lpage><pub-id pub-id-type="pmid">31981498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.athoracsur.2019.11.052</pub-id></mixed-citation></ref><ref id="bib30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iezzoni</surname><given-names>LI</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>LH</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Roetzheim</surname><given-names>RG</given-names></name><name name-style="western"><surname>Drews</surname><given-names>RE</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>EP</given-names></name></person-group><article-title>Treatment disparities for disabled Medicare beneficiaries with stage I non-small cell lung cancer</article-title><source><italic toggle="yes">Arch Phys Med Rehabil</italic></source><year>2008</year><volume>89</volume><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">18373987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apmr.2007.09.042</pub-id></mixed-citation></ref><ref id="bib31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fujiwara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Theodoropoulos</surname><given-names>N</given-names></name><name name-style="western"><surname>Xie</surname><given-names>H</given-names></name><name name-style="western"><surname>Kurbanova</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name></person-group><article-title>P09.19 health disparities characteristics in cancer survivorships among sexual minorities in the US&#8212;a cross-sectional study using BRFSS 2018 data</article-title><source><italic toggle="yes">J Thorac Oncol</italic></source><year>2021</year><volume>16</volume><fpage>S297</fpage><lpage>S298</lpage></mixed-citation></ref><ref id="bib32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>KH</given-names></name><name name-style="western"><surname>Bradford</surname><given-names>JB</given-names></name><name name-style="western"><surname>Makadon</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Stall</surname><given-names>R</given-names></name><name name-style="western"><surname>Goldhammer</surname><given-names>H</given-names></name><name name-style="western"><surname>Landers</surname><given-names>S</given-names></name></person-group><article-title>Sexual and gender minority health: what we know and what needs to be done</article-title><source><italic toggle="yes">Am J Public Health</italic></source><year>2008</year><volume>98</volume><fpage>989</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">18445789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2007.127811</pub-id><pub-id pub-id-type="pmcid">PMC2377288</pub-id></mixed-citation></ref><ref id="bib33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veliz</surname><given-names>P</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>AK</given-names></name><name name-style="western"><surname>Arslanian-Engoren</surname><given-names>C</given-names></name><name name-style="western"><surname>Evans-Polce</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JGL</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>CJ</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>LDCT lung cancer screening eligibility and use of CT scans for lung cancer among sexual minorities</article-title><source><italic toggle="yes">Cancer Epidemiol</italic></source><year>2019</year><volume>60</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">30909153</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canep.2019.03.009</pub-id><pub-id pub-id-type="pmcid">PMC6527458</pub-id></mixed-citation></ref><ref id="bib34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stowell</surname><given-names>JT</given-names></name><name name-style="western"><surname>Parikh</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tilson</surname><given-names>K</given-names></name><name name-style="western"><surname>Narayan</surname><given-names>AK</given-names></name></person-group><article-title>Lung cancer screening eligibility and utilization among transgender patients: an analysis of the 2017&#8211;2018 United States Behavioral Risk Factor Surveillance System survey</article-title><source><italic toggle="yes">Nicotine Tob Res</italic></source><year>2020</year><volume>22</volume><fpage>2164</fpage><lpage>2169</lpage><pub-id pub-id-type="pmid">32623455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntaa127</pub-id></mixed-citation></ref><ref id="bib35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winstone</surname><given-names>TA</given-names></name><name name-style="western"><surname>Man</surname><given-names>SFP</given-names></name><name name-style="western"><surname>Hull</surname><given-names>M</given-names></name><name name-style="western"><surname>Montaner</surname><given-names>JS</given-names></name><name name-style="western"><surname>Sin</surname><given-names>DD</given-names></name></person-group><article-title>Epidemic of lung cancer in patients with HIV infection</article-title><source><italic toggle="yes">Chest</italic></source><year>2013</year><volume>143</volume><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">23381313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.12-1699</pub-id><pub-id pub-id-type="pmcid">PMC3619638</pub-id></mixed-citation></ref><ref id="bib36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houston</surname><given-names>KA</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>KA</given-names></name><name name-style="western"><surname>King</surname><given-names>J</given-names></name><name name-style="western"><surname>White</surname><given-names>A</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>BM</given-names></name></person-group><article-title>Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county</article-title><source><italic toggle="yes">J Thorac Oncol</italic></source><year>2018</year><volume>13</volume><fpage>497</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">29360512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtho.2017.12.010</pub-id><pub-id pub-id-type="pmcid">PMC5884169</pub-id></mixed-citation></ref><ref id="bib37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Leon</surname><given-names>J</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>T</given-names></name><name name-style="western"><surname>Browne</surname><given-names>D</given-names></name><name name-style="western"><surname>Dinsmore</surname><given-names>L</given-names></name></person-group><article-title>Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders</article-title><source><italic toggle="yes">Schizophr Res</italic></source><year>2002</year><volume>56</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">12084419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0920-9964(01)00217-1</pub-id></mixed-citation></ref><ref id="bib38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>CD</given-names></name><name name-style="western"><surname>Giese</surname><given-names>AA</given-names></name><name name-style="western"><surname>Turnbull</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Dickinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Johnson-Nagel</surname><given-names>N</given-names></name></person-group><article-title>Predictors of tobacco use among persons with mental illnesses in a statewide population</article-title><source><italic toggle="yes">Psychiatr Serv</italic></source><year>2006</year><volume>57</volume><fpage>1035</fpage><lpage>1038</lpage><pub-id pub-id-type="pmid">16816291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/ps.2006.57.7.1035</pub-id></mixed-citation></ref><ref id="bib39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Rendon</surname><given-names>DM</given-names></name><name name-style="western"><surname>Vel&#225;squez</surname><given-names>DM</given-names></name><name name-style="western"><surname>Susce</surname><given-names>MT</given-names></name><name name-style="western"><surname>de Leon</surname><given-names>J</given-names></name></person-group><article-title>Datapoints: smoking and smoking cessation among persons with severe mental illnesses</article-title><source><italic toggle="yes">Psychiatr Serv</italic></source><year>2006</year><volume>57</volume><fpage>462</fpage><pub-id pub-id-type="pmid">16603739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/ps.2006.57.4.462</pub-id></mixed-citation></ref><ref id="bib40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergamo</surname><given-names>C</given-names></name><name name-style="western"><surname>Sigel</surname><given-names>K</given-names></name><name name-style="western"><surname>Mhango</surname><given-names>G</given-names></name><name name-style="western"><surname>Kale</surname><given-names>M</given-names></name><name name-style="western"><surname>Wisnivesky</surname><given-names>JP</given-names></name></person-group><article-title>Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study</article-title><source><italic toggle="yes">Psychosom Med</italic></source><year>2014</year><volume>76</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">24677164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PSY.0000000000000050</pub-id><pub-id pub-id-type="pmcid">PMC4747031</pub-id></mixed-citation></ref><ref id="bib41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>E</given-names></name><name name-style="western"><surname>Rouillon</surname><given-names>F</given-names></name><name name-style="western"><surname>Loze</surname><given-names>JY</given-names></name><name name-style="western"><surname>Casadebaig</surname><given-names>F</given-names></name><name name-style="western"><surname>Philippe</surname><given-names>A</given-names></name><name name-style="western"><surname>Vitry</surname><given-names>F</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study</article-title><source><italic toggle="yes">Cancer</italic></source><year>2009</year><volume>115</volume><fpage>3555</fpage><lpage>3562</lpage><pub-id pub-id-type="pmid">19548261</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.24383</pub-id></mixed-citation></ref><ref id="bib42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>McGlynn</surname><given-names>KA</given-names></name><name name-style="western"><surname>Carter</surname><given-names>CA</given-names></name><name name-style="western"><surname>Nations</surname><given-names>JA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>WF</given-names></name><name name-style="western"><surname>Shriver</surname><given-names>CD</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>The impact of preexisting mental health disorders on the diagnosis, treatment, and survival among lung cancer patients in the U.S. military health system</article-title><source><italic toggle="yes">Cancer Epidemiol Biomarkers Prev</italic></source><year>2016</year><volume>25</volume><fpage>1564</fpage><lpage>1571</lpage><pub-id pub-id-type="pmid">27566418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-16-0316</pub-id><pub-id pub-id-type="pmcid">PMC5777503</pub-id></mixed-citation></ref><ref id="bib43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arrieta</surname><given-names>O</given-names></name><name name-style="western"><surname>Angulo</surname><given-names>LP</given-names></name><name name-style="western"><surname>N&#250;&#241;ez-Valencia</surname><given-names>C</given-names></name><name name-style="western"><surname>Dorantes-Gallareta</surname><given-names>Y</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>EO</given-names></name><name name-style="western"><surname>Mart&#237;nez-L&#243;pez</surname><given-names>D</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer</article-title><source><italic toggle="yes">Ann Surg Oncol</italic></source><year>2013</year><volume>20</volume><fpage>1941</fpage><lpage>1948</lpage><pub-id pub-id-type="pmid">23263699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1245/s10434-012-2793-5</pub-id></mixed-citation></ref><ref id="bib44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lederer</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bell</surname><given-names>SC</given-names></name><name name-style="western"><surname>Branson</surname><given-names>RD</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>JD</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>R</given-names></name><name name-style="western"><surname>Maslove</surname><given-names>DM</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Control of confounding and reporting of results in causal inference studies: guidance for authors from editors of respiratory, sleep, and critical care journals</article-title><source><italic toggle="yes">Ann Am Thorac Soc</italic></source><year>2019</year><volume>16</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">30230362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201808-564PS</pub-id></mixed-citation></ref><ref id="bib45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kats</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Tlimat</surname><given-names>A</given-names></name><name name-style="western"><surname>Perzynski</surname><given-names>A</given-names></name><name name-style="western"><surname>Dalton</surname><given-names>J</given-names></name><name name-style="western"><surname>Gunzler</surname><given-names>D</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Neighborhood disadvantage and lung cancer incidence in ever-smokers at a safety net health-care system: a retrospective study</article-title><source><italic toggle="yes">Chest</italic></source><year>2020</year><volume>157</volume><fpage>1021</fpage><lpage>1029</lpage><pub-id pub-id-type="pmid">31862438</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2019.11.033</pub-id><pub-id pub-id-type="pmcid">PMC7268431</pub-id></mixed-citation></ref><ref id="bib46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Namburi</surname><given-names>N</given-names></name><name name-style="western"><surname>Timsina</surname><given-names>L</given-names></name><name name-style="western"><surname>Ninad</surname><given-names>N</given-names></name><name name-style="western"><surname>Ceppa</surname><given-names>D</given-names></name><name name-style="western"><surname>Birdas</surname><given-names>T</given-names></name></person-group><article-title>The impact of social determinants of health on management of stage I non-small cell lung cancer</article-title><source><italic toggle="yes">Am J Surg</italic></source><year>2022</year><volume>223</volume><fpage>1063</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">34663500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2021.10.022</pub-id></mixed-citation></ref><ref id="bib47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulson</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kenzik</surname><given-names>KM</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Pavesi</surname><given-names>F</given-names></name><name name-style="western"><surname>Steiling</surname><given-names>K</given-names></name><name name-style="western"><surname>Litle</surname><given-names>VR</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Redlining, structural racism, and lung cancer screening disparities</article-title><source><italic toggle="yes">J Thorac Cardiovasc Surg</italic></source><year>2021</year><volume>163</volume><fpage>1920</fpage><lpage>1930.e2</lpage><pub-id pub-id-type="pmid">34774325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jtcvs.2021.08.086</pub-id></mixed-citation></ref><ref id="bib48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barta</surname><given-names>JA</given-names></name><name name-style="western"><surname>Shusted</surname><given-names>CS</given-names></name><name name-style="western"><surname>Ruane</surname><given-names>B</given-names></name><name name-style="western"><surname>Pimpinelli</surname><given-names>M</given-names></name><name name-style="western"><surname>McIntire</surname><given-names>RK</given-names></name><name name-style="western"><surname>Zeigler-Johnson</surname><given-names>C</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Racial differences in lung cancer screening beliefs and screening adherence</article-title><source><italic toggle="yes">Clin Lung Cancer</italic></source><year>2021</year><volume>22</volume><fpage>570</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">34257020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cllc.2021.06.003</pub-id></mixed-citation></ref><ref id="bib49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Floyd</surname><given-names>A</given-names></name><name name-style="western"><surname>Sakellariou</surname><given-names>D</given-names></name></person-group><article-title>Healthcare access for refugee women with limited literacy: layers of disadvantage</article-title><source><italic toggle="yes">Int J Equity Health</italic></source><year>2017</year><volume>16</volume><fpage>195</fpage><pub-id pub-id-type="pmid">29126420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12939-017-0694-8</pub-id><pub-id pub-id-type="pmcid">PMC5681803</pub-id></mixed-citation></ref><ref id="bib50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Divi</surname><given-names>C</given-names></name><name name-style="western"><surname>Koss</surname><given-names>RG</given-names></name><name name-style="western"><surname>Schmaltz</surname><given-names>SP</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>JM</given-names></name></person-group><article-title>Language proficiency and adverse events in US hospitals: a pilot study</article-title><source><italic toggle="yes">Int J Qual Health Care</italic></source><year>2007</year><volume>19</volume><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">17277013</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/intqhc/mzl069</pub-id></mixed-citation></ref><ref id="bib51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>SH</given-names></name><name name-style="western"><surname>Cummins</surname><given-names>SE</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S</given-names></name><name name-style="western"><surname>Gamst</surname><given-names>AC</given-names></name><name name-style="western"><surname>Tedeschi</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Reyes-Nocon</surname><given-names>J</given-names></name></person-group><article-title>The effects of a multilingual telephone quitline for Asian smokers: a randomized controlled trial</article-title><source><italic toggle="yes">J Natl Cancer Inst</italic></source><year>2012</year><volume>104</volume><fpage>299</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">22282542</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djr530</pub-id><pub-id pub-id-type="pmcid">PMC3283535</pub-id></mixed-citation></ref><ref id="bib52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>RF</given-names></name><name name-style="western"><surname>Barrera</surname><given-names>AZ</given-names></name><name name-style="western"><surname>Delucchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Penilla</surname><given-names>C</given-names></name><name name-style="western"><surname>Torres</surname><given-names>LD</given-names></name><name name-style="western"><surname>P&#233;rez-Stable</surname><given-names>EJ</given-names></name></person-group><article-title>International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year</article-title><source><italic toggle="yes">Nicotine Tob Res</italic></source><year>2009</year><volume>11</volume><fpage>1025</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">19640833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntp090</pub-id><pub-id pub-id-type="pmcid">PMC2725004</pub-id></mixed-citation></ref><ref id="bib53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voorhees</surname><given-names>K</given-names></name><name name-style="western"><surname>Fernald</surname><given-names>DH</given-names></name><name name-style="western"><surname>Emsermann</surname><given-names>C</given-names></name><name name-style="western"><surname>Zittleman</surname><given-names>L</given-names></name><name name-style="western"><surname>Smith</surname><given-names>PC</given-names></name><name name-style="western"><surname>Parnes</surname><given-names>B</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>State Networks of Colorado Ambulatory Practices and Partners</collab></person-group><article-title>Underinsurance in primary care: a report from the State Networks of Colorado Ambulatory Practices and Partners (SNOCAP)</article-title><source><italic toggle="yes">J Am Board Fam Med</italic></source><year>2008</year><volume>21</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">18612057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2008.04.080001</pub-id></mixed-citation></ref><ref id="bib54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trivedi</surname><given-names>AN</given-names></name><name name-style="western"><surname>Rakowski</surname><given-names>W</given-names></name><name name-style="western"><surname>Ayanian</surname><given-names>JZ</given-names></name></person-group><article-title>Effect of cost sharing on screening mammography in Medicare health plans</article-title><source><italic toggle="yes">N Engl J Med</italic></source><year>2008</year><volume>358</volume><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">18216358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMsa070929</pub-id></mixed-citation></ref><ref id="bib55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varkey</surname><given-names>AB</given-names></name><name name-style="western"><surname>Manwell</surname><given-names>LB</given-names></name><name name-style="western"><surname>Williams</surname><given-names>ES</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>SA</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RL</given-names></name><name name-style="western"><surname>Bobula</surname><given-names>JA</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>MEMO Investigators</collab></person-group><article-title>Separate and unequal: clinics where minority and nonminority patients receive primary care</article-title><source><italic toggle="yes">Arch Intern Med</italic></source><year>2009</year><volume>169</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">19204215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinternmed.2008.559</pub-id></mixed-citation></ref><ref id="bib56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meade</surname><given-names>CD</given-names></name><name name-style="western"><surname>Wells</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Arevalo</surname><given-names>M</given-names></name><name name-style="western"><surname>Calcano</surname><given-names>ER</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>M</given-names></name><name name-style="western"><surname>Sarmiento</surname><given-names>Y</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Lay navigator model for impacting cancer health disparities</article-title><source><italic toggle="yes">J Cancer Educ</italic></source><year>2014</year><volume>29</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">24683043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13187-014-0640-z</pub-id><pub-id pub-id-type="pmcid">PMC4133280</pub-id></mixed-citation></ref><ref id="bib57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oluwole</surname><given-names>SF</given-names></name><name name-style="western"><surname>Ali</surname><given-names>AO</given-names></name><name name-style="western"><surname>Adu</surname><given-names>A</given-names></name><name name-style="western"><surname>Blane</surname><given-names>BP</given-names></name><name name-style="western"><surname>Barlow</surname><given-names>B</given-names></name><name name-style="western"><surname>Oropeza</surname><given-names>R</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community</article-title><source><italic toggle="yes">J Am Coll Surg</italic></source><year>2003</year><volume>196</volume><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">12595043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1072-7515(02)01765-9</pub-id></mixed-citation></ref><ref id="bib58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molina</surname><given-names>Y</given-names></name><name name-style="western"><surname>Glassgow</surname><given-names>AE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Berrios</surname><given-names>NM</given-names></name><name name-style="western"><surname>Pauls</surname><given-names>H</given-names></name><name name-style="western"><surname>Watson</surname><given-names>KS</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Patient navigation in medically underserved areas study design: a trial with implications for efficacy, effect modification, and full continuum assessment</article-title><source><italic toggle="yes">Contemp Clin Trials</italic></source><year>2017</year><volume>53</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">27940186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cct.2016.12.001</pub-id><pub-id pub-id-type="pmcid">PMC5274626</pub-id></mixed-citation></ref><ref id="bib59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez</surname><given-names>AG</given-names></name><name name-style="western"><surname>P&#233;rez-Stable</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Talavera</surname><given-names>GA</given-names></name><name name-style="western"><surname>Penedo</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Carrillo</surname><given-names>JE</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>ME</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study</article-title><source><italic toggle="yes">Springerplus</italic></source><year>2013</year><volume>2</volume><fpage>84</fpage><pub-id pub-id-type="pmid">23519779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/2193-1801-2-84</pub-id><pub-id pub-id-type="pmcid">PMC3601250</pub-id></mixed-citation></ref><ref id="bib60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freund</surname><given-names>KM</given-names></name><name name-style="western"><surname>Battaglia</surname><given-names>TA</given-names></name><name name-style="western"><surname>Calhoun</surname><given-names>E</given-names></name><name name-style="western"><surname>Darnell</surname><given-names>JS</given-names></name><name name-style="western"><surname>Dudley</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Fiscella</surname><given-names>K</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>Writing Group of the Patient Navigation Research Program</collab></person-group><article-title>Impact of patient navigation on timely cancer care: the Patient Navigation Research Program</article-title><source><italic toggle="yes">J Natl Cancer Inst</italic></source><year>2014</year><volume>106</volume><fpage>dju115</fpage><pub-id pub-id-type="pmid">24938303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/dju115</pub-id><pub-id pub-id-type="pmcid">PMC4072900</pub-id></mixed-citation></ref><ref id="bib61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinstock</surname><given-names>TG</given-names></name><name name-style="western"><surname>Tewari</surname><given-names>A</given-names></name><name name-style="western"><surname>Patel</surname><given-names>H</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>K</given-names></name><name name-style="western"><surname>Tananbaum</surname><given-names>R</given-names></name><name name-style="western"><surname>Flores</surname><given-names>A</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>No stone unturned: Nodule Net, an intervention to reduce loss to follow-up of lung nodules</article-title><source><italic toggle="yes">Respir Med</italic></source><year>2019</year><volume>157</volume><fpage>49</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">31518707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.rmed.2019.09.003</pub-id></mixed-citation></ref><ref id="bib62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mokdad</surname><given-names>AH</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>BA</given-names></name><name name-style="western"><surname>Ford</surname><given-names>ES</given-names></name><name name-style="western"><surname>Vinicor</surname><given-names>F</given-names></name><name name-style="western"><surname>Marks</surname><given-names>JS</given-names></name><name name-style="western"><surname>Koplan</surname><given-names>JP</given-names></name></person-group><article-title>The continuing epidemics of obesity and diabetes in the United States</article-title><source><italic toggle="yes">JAMA</italic></source><year>2001</year><volume>286</volume><fpage>1195</fpage><lpage>1200</lpage><pub-id pub-id-type="pmid">11559264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.286.10.1195</pub-id></mixed-citation></ref><ref id="bib63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>SSS</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>MD</given-names></name><name name-style="western"><surname>Fryar</surname><given-names>CD</given-names></name></person-group><article-title>Hypertension prevalence and control among adults: United States, 2011&#8211;2014</article-title><source><italic toggle="yes">NCHS Data Brief</italic></source><year>2015</year><volume>(220)</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">26633197</pub-id></mixed-citation></ref><ref id="bib64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>G</given-names></name></person-group><article-title>Disparities in cardiovascular disease risk in the United States</article-title><source><italic toggle="yes">Curr Cardiol Rev</italic></source><year>2015</year><volume>11</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">25418513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1573403X11666141122220003</pub-id><pub-id pub-id-type="pmcid">PMC4558355</pub-id></mixed-citation></ref><ref id="bib65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patzer</surname><given-names>RE</given-names></name><name name-style="western"><surname>McClellan</surname><given-names>WM</given-names></name></person-group><article-title>Influence of race, ethnicity and socioeconomic status on kidney disease</article-title><source><italic toggle="yes">Nat Rev Nephrol</italic></source><year>2012</year><volume>8</volume><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">22735764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrneph.2012.117</pub-id><pub-id pub-id-type="pmcid">PMC3950900</pub-id></mixed-citation></ref><ref id="bib66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimmick</surname><given-names>G</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>ST</given-names></name><name name-style="western"><surname>Sabatino</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XC</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>W</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>JF</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>Centers for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group</collab></person-group><article-title>Comorbidity burden and guideline-concordant care for breast cancer</article-title><source><italic toggle="yes">J Am Geriatr Soc</italic></source><year>2014</year><volume>62</volume><fpage>482</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">24512124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgs.12687</pub-id><pub-id pub-id-type="pmcid">PMC5869701</pub-id></mixed-citation></ref><ref id="bib67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruterbusch</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Ali-Fehmi</surname><given-names>R</given-names></name><name name-style="western"><surname>Olson</surname><given-names>SH</given-names></name><name name-style="western"><surname>Sealy-Jefferson</surname><given-names>S</given-names></name><name name-style="western"><surname>Rybicki</surname><given-names>BA</given-names></name><name name-style="western"><surname>Hensley-Alford</surname><given-names>S</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>The influence of comorbid conditions on racial disparities in endometrial cancer survival</article-title><source><italic toggle="yes">Am J Obstet Gynecol</italic></source><year>2014</year><volume>211</volume><fpage>627.e1</fpage><lpage>627.e9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2014.06.036</pub-id><pub-id pub-id-type="pmcid">PMC4253020</pub-id><pub-id pub-id-type="pmid">24954655</pub-id></mixed-citation></ref><ref id="bib68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tammemagi</surname><given-names>CM</given-names></name><name name-style="western"><surname>Nerenz</surname><given-names>D</given-names></name><name name-style="western"><surname>Neslund-Dudas</surname><given-names>C</given-names></name><name name-style="western"><surname>Feldkamp</surname><given-names>C</given-names></name><name name-style="western"><surname>Nathanson</surname><given-names>D</given-names></name></person-group><article-title>Comorbidity and survival disparities among black and white patients with breast cancer</article-title><source><italic toggle="yes">JAMA</italic></source><year>2005</year><volume>294</volume><fpage>1765</fpage><lpage>1772</lpage><pub-id pub-id-type="pmid">16219879</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.294.14.1765</pub-id></mixed-citation></ref><ref id="bib69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duma</surname><given-names>N</given-names></name><name name-style="western"><surname>Kothadia</surname><given-names>SM</given-names></name><name name-style="western"><surname>Azam</surname><given-names>TU</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>S</given-names></name><name name-style="western"><surname>Paludo</surname><given-names>J</given-names></name><name name-style="western"><surname>Vera Aguilera</surname><given-names>J</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials</article-title><source><italic toggle="yes">Oncologist</italic></source><year>2019</year><volume>24</volume><fpage>96</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">30413668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1634/theoncologist.2017-0687</pub-id><pub-id pub-id-type="pmcid">PMC6324635</pub-id></mixed-citation></ref><ref id="bib70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suneja</surname><given-names>G</given-names></name><name name-style="western"><surname>Shiels</surname><given-names>MS</given-names></name><name name-style="western"><surname>Melville</surname><given-names>SK</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MA</given-names></name><name name-style="western"><surname>Rengan</surname><given-names>R</given-names></name><name name-style="western"><surname>Engels</surname><given-names>EA</given-names></name></person-group><article-title>Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals</article-title><source><italic toggle="yes">AIDS</italic></source><year>2013</year><volume>27</volume><fpage>459</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">23079809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e32835ad56e</pub-id><pub-id pub-id-type="pmcid">PMC3595594</pub-id></mixed-citation></ref><ref id="bib71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blom</surname><given-names>EF</given-names></name><name name-style="western"><surname>Ten Haaf</surname><given-names>K</given-names></name><name name-style="western"><surname>Arenberg</surname><given-names>DA</given-names></name><name name-style="western"><surname>de Koning</surname><given-names>HJ</given-names></name></person-group><article-title>Disparities in receiving guideline-concordant treatment for lung cancer in the United States</article-title><source><italic toggle="yes">Ann Am Thorac Soc</italic></source><year>2020</year><volume>17</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">31672025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201901-094OC</pub-id><pub-id pub-id-type="pmcid">PMC6993802</pub-id></mixed-citation></ref><ref id="bib72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fowler</surname><given-names>H</given-names></name><name name-style="western"><surname>Belot</surname><given-names>A</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>L</given-names></name><name name-style="western"><surname>Maringe</surname><given-names>C</given-names></name><name name-style="western"><surname>Luque-Fernandez</surname><given-names>MA</given-names></name><name name-style="western"><surname>Njagi</surname><given-names>EN</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers</article-title><source><italic toggle="yes">BMC Cancer</italic></source><year>2020</year><volume>20</volume><fpage>2</fpage><pub-id pub-id-type="pmid">31987032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-019-6472-9</pub-id><pub-id pub-id-type="pmcid">PMC6986047</pub-id></mixed-citation></ref><ref id="bib73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freeman</surname><given-names>HP</given-names></name><name name-style="western"><surname>Muth</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Kerner</surname><given-names>JF</given-names></name></person-group><article-title>Expanding access to cancer screening and clinical follow-up among the medically underserved</article-title><source><italic toggle="yes">Cancer Pract</italic></source><year>1995</year><volume>3</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7704057</pub-id></mixed-citation></ref><ref id="bib74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paskett</surname><given-names>ED</given-names></name><name name-style="western"><surname>Katz</surname><given-names>ML</given-names></name><name name-style="western"><surname>Post</surname><given-names>DM</given-names></name><name name-style="western"><surname>Pennell</surname><given-names>ML</given-names></name><name name-style="western"><surname>Young</surname><given-names>GS</given-names></name><name name-style="western"><surname>Seiber</surname><given-names>EE</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal><collab>Ohio Patient Navigation Research Program</collab></person-group><article-title>The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?</article-title><source><italic toggle="yes">Cancer Epidemiol Biomarkers Prev</italic></source><year>2012</year><volume>21</volume><fpage>1620</fpage><lpage>1628</lpage><pub-id pub-id-type="pmid">23045536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-12-0523</pub-id><pub-id pub-id-type="pmcid">PMC3785236</pub-id></mixed-citation></ref><ref id="bib75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirintrapun</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>AM</given-names></name></person-group><article-title>Telemedicine in cancer care</article-title><source><italic toggle="yes">Am Soc Clin Oncol Educ Book</italic></source><year>2018</year><volume>38</volume><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">30231354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/EDBK_200141</pub-id></mixed-citation></ref><ref id="bib76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivera</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kataki</surname><given-names>HA</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>NT</given-names></name><name name-style="western"><surname>Triplette</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakoda</surname><given-names>LC</given-names></name><name name-style="western"><surname>Wiener</surname><given-names>RS</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Addressing disparities in lung cancer screening eligibility and health care access: an official ATS statement</article-title><source><italic toggle="yes">Am J Respir Crit Care Med</italic></source><year>2020</year><volume>202</volume><fpage>e95</fpage><lpage>e112</lpage><pub-id pub-id-type="pmid">33000953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202008-3053ST</pub-id><pub-id pub-id-type="pmcid">PMC7528802</pub-id></mixed-citation></ref><ref id="bib77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Percac-Lima</surname><given-names>S</given-names></name><name name-style="western"><surname>Cronin</surname><given-names>PR</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>DP</given-names></name><name name-style="western"><surname>Chabner</surname><given-names>BA</given-names></name><name name-style="western"><surname>Daly</surname><given-names>EA</given-names></name><name name-style="western"><surname>Kimball</surname><given-names>AB</given-names></name></person-group><article-title>Patient navigation based on predictive modeling decreases no-show rates in cancer care</article-title><source><italic toggle="yes">Cancer</italic></source><year>2015</year><volume>121</volume><fpage>1662</fpage><lpage>1670</lpage><pub-id pub-id-type="pmid">25585595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.29236</pub-id></mixed-citation></ref><ref id="bib78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Champion</surname><given-names>VL</given-names></name><name name-style="western"><surname>Skinner</surname><given-names>CS</given-names></name><name name-style="western"><surname>Menon</surname><given-names>U</given-names></name><name name-style="western"><surname>Seshadri</surname><given-names>R</given-names></name><name name-style="western"><surname>Anzalone</surname><given-names>DC</given-names></name><name name-style="western"><surname>Rawl</surname><given-names>SM</given-names></name></person-group><article-title>Comparisons of tailored mammography interventions at two months postintervention</article-title><source><italic toggle="yes">Ann Behav Med</italic></source><year>2002</year><volume>24</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">12173678</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1207/S15324796ABM2403_06</pub-id></mixed-citation></ref><ref id="bib79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janz</surname><given-names>NK</given-names></name><name name-style="western"><surname>Schottenfeld</surname><given-names>D</given-names></name><name name-style="western"><surname>Doerr</surname><given-names>KM</given-names></name><name name-style="western"><surname>Selig</surname><given-names>SM</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>RL</given-names></name><name name-style="western"><surname>Strawderman</surname><given-names>M</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>A two-step intervention of increase mammography among women aged 65 and older</article-title><source><italic toggle="yes">Am J Public Health</italic></source><year>1997</year><volume>87</volume><fpage>1683</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">9357355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/ajph.87.10.1683</pub-id><pub-id pub-id-type="pmcid">PMC1381136</pub-id></mixed-citation></ref><ref id="bib80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beauchamp</surname><given-names>A</given-names></name><name name-style="western"><surname>Mohebbi</surname><given-names>M</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>A</given-names></name><name name-style="western"><surname>Pridmore</surname><given-names>V</given-names></name><name name-style="western"><surname>Livingston</surname><given-names>P</given-names></name><name name-style="western"><surname>Scanlon</surname><given-names>M</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>The impact of translated reminder letters and phone calls on mammography screening booking rates: two randomised controlled trials</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2020</year><volume>15</volume><fpage>e0226610</fpage><pub-id pub-id-type="pmid">31923178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0226610</pub-id><pub-id pub-id-type="pmcid">PMC6953872</pub-id></mixed-citation></ref><ref id="bib81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiener</surname><given-names>RS</given-names></name><name name-style="western"><surname>Gould</surname><given-names>MK</given-names></name><name name-style="western"><surname>Woloshin</surname><given-names>S</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>LM</given-names></name><name name-style="western"><surname>Clark</surname><given-names>JA</given-names></name></person-group><article-title>What do you mean, a spot? A qualitative analysis of patients&#8217; reactions to discussions with their physicians about pulmonary nodules</article-title><source><italic toggle="yes">Chest</italic></source><year>2013</year><volume>143</volume><fpage>672</fpage><lpage>677</lpage><pub-id pub-id-type="pmid">22814873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.12-1095</pub-id><pub-id pub-id-type="pmcid">PMC3590883</pub-id></mixed-citation></ref><ref id="bib82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lake</surname><given-names>J</given-names></name><name name-style="western"><surname>Wall</surname><given-names>MM</given-names></name><name name-style="western"><surname>Berman</surname><given-names>AR</given-names></name><name name-style="western"><surname>Salazar-Schicchi</surname><given-names>J</given-names></name><name name-style="western"><surname>Powell</surname><given-names>C</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Association of patient-provider communication domains with lung cancer treatment</article-title><source><italic toggle="yes">J Thorac Oncol</italic></source><year>2014</year><volume>9</volume><fpage>1249</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">25122421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JTO.0000000000000281</pub-id><pub-id pub-id-type="pmcid">PMC4133738</pub-id></mixed-citation></ref><ref id="bib83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiener</surname><given-names>RS</given-names></name><name name-style="western"><surname>Clark</surname><given-names>JA</given-names></name><name name-style="western"><surname>Koppelman</surname><given-names>E</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>R</given-names></name><name name-style="western"><surname>Fix</surname><given-names>GM</given-names></name><name name-style="western"><surname>Slatore</surname><given-names>CG</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Patient vs clinician perspectives on communication about results of lung cancer screening: a qualitative study</article-title><source><italic toggle="yes">Chest</italic></source><year>2020</year><volume>158</volume><fpage>1240</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">32387521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2020.03.081</pub-id><pub-id pub-id-type="pmcid">PMC7478230</pub-id></mixed-citation></ref><ref id="bib84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeshita</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Loren</surname><given-names>AW</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>N</given-names></name><name name-style="western"><surname>Shults</surname><given-names>J</given-names></name><name name-style="western"><surname>Shin</surname><given-names>DB</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Association of racial/ethnic and gender concordance between patients and physicians with patient experience ratings</article-title><source><italic toggle="yes">JAMA Netw Open</italic></source><year>2020</year><volume>3</volume><fpage>e2024583</fpage><pub-id pub-id-type="pmid">33165609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2020.24583</pub-id><pub-id pub-id-type="pmcid">PMC7653497</pub-id></mixed-citation></ref><ref id="bib85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warner</surname><given-names>ET</given-names></name><name name-style="western"><surname>Lathan</surname><given-names>CS</given-names></name></person-group><article-title>Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013&#8211;2017</article-title><source><italic toggle="yes">Prev Med</italic></source><year>2019</year><volume>124</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">31054908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ypmed.2019.05.001</pub-id></mixed-citation></ref><ref id="bib86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-Stable</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Afable-Munsuz</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>CP</given-names></name><name name-style="western"><surname>Pace</surname><given-names>L</given-names></name><name name-style="western"><surname>Samayoa</surname><given-names>C</given-names></name><name name-style="western"><surname>Somkin</surname><given-names>C</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Factors influencing time to diagnosis after abnormal mammography in diverse women</article-title><source><italic toggle="yes">J Womens Health</italic></source><year>2013</year><volume>22</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/jwh.2012.3646</pub-id><pub-id pub-id-type="pmcid">PMC3573728</pub-id><pub-id pub-id-type="pmid">23350859</pub-id></mixed-citation></ref><ref id="bib87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penner</surname><given-names>LA</given-names></name><name name-style="western"><surname>Dovidio</surname><given-names>JF</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>R</given-names></name><name name-style="western"><surname>Albrecht</surname><given-names>TL</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>R</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>The effects of oncologist implicit racial bias in racially discordant oncology interactions</article-title><source><italic toggle="yes">J Clin Oncol</italic></source><year>2016</year><volume>34</volume><fpage>2874</fpage><lpage>2880</lpage><pub-id pub-id-type="pmid">27325865</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2015.66.3658</pub-id><pub-id pub-id-type="pmcid">PMC5012663</pub-id></mixed-citation></ref><ref id="bib88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagiwara</surname><given-names>N</given-names></name><name name-style="western"><surname>Slatcher</surname><given-names>RB</given-names></name><name name-style="western"><surname>Eggly</surname><given-names>S</given-names></name><name name-style="western"><surname>Penner</surname><given-names>LA</given-names></name></person-group><article-title>Physician racial bias and word use during racially discordant medical interactions</article-title><source><italic toggle="yes">Health Commun</italic></source><year>2017</year><volume>32</volume><fpage>401</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">27309596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10410236.2016.1138389</pub-id><pub-id pub-id-type="pmcid">PMC5161737</pub-id></mixed-citation></ref><ref id="bib89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazzone</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Gould</surname><given-names>MK</given-names></name><name name-style="western"><surname>Arenberg</surname><given-names>DA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Choi</surname><given-names>HK</given-names></name><name name-style="western"><surname>Detterbeck</surname><given-names>FC</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST expert panel report</article-title><source><italic toggle="yes">Chest</italic></source><year>2020</year><volume>158</volume><fpage>406</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">32335067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2020.04.020</pub-id><pub-id pub-id-type="pmcid">PMC7177089</pub-id></mixed-citation></ref><ref id="bib90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>PS</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>D</given-names></name><name name-style="western"><surname>Sternlieb</surname><given-names>J</given-names></name><name name-style="western"><surname>Taupin</surname><given-names>M</given-names></name><name name-style="western"><surname>Sich</surname><given-names>N</given-names></name><name name-style="western"><surname>Dian</surname><given-names>J</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Process improvement for follow-up radiology report recommendations of lung nodules</article-title><source><italic toggle="yes">BMJ Open Qual</italic></source><year>2019</year><volume>8</volume><fpage>e000370</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjoq-2018-000370</pub-id><pub-id pub-id-type="pmcid">PMC6542430</pub-id><pub-id pub-id-type="pmid">31206047</pub-id></mixed-citation></ref><ref id="bib91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>DM</given-names></name><name name-style="western"><surname>Linder</surname><given-names>JA</given-names></name><name name-style="western"><surname>Landon</surname><given-names>BE</given-names></name></person-group><article-title>Characteristics of Americans with primary care and changes over time, 2002&#8211;2015</article-title><source><italic toggle="yes">JAMA Intern Med</italic></source><year>2020</year><volume>180</volume><fpage>463</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">31841583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2019.6282</pub-id><pub-id pub-id-type="pmcid">PMC6990950</pub-id></mixed-citation></ref><ref id="bib92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>JT</given-names></name></person-group><article-title>The inverse care law</article-title><source><italic toggle="yes">Lancet</italic></source><year>1971</year><volume>1</volume><fpage>405</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">4100731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(71)92410-x</pub-id></mixed-citation></ref><ref id="bib93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eberth</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bozorgi</surname><given-names>P</given-names></name><name name-style="western"><surname>Lebr&#243;n</surname><given-names>LM</given-names></name><name name-style="western"><surname>Bills</surname><given-names>SE</given-names></name><name name-style="western"><surname>Hazlett</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Carlos</surname><given-names>RC</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Geographic availability of low-dose computed tomography for lung cancer screening in the United States, 2017</article-title><source><italic toggle="yes">Prev Chronic Dis</italic></source><year>2018</year><volume>15</volume><fpage>E119</fpage><pub-id pub-id-type="pmid">30289107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5888/pcd15.180241</pub-id><pub-id pub-id-type="pmcid">PMC6178901</pub-id></mixed-citation></ref><ref id="bib94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#252;tte</surname><given-names>S</given-names></name><name name-style="western"><surname>Dietrich</surname><given-names>D</given-names></name><name name-style="western"><surname>Montet</surname><given-names>X</given-names></name><name name-style="western"><surname>Flahault</surname><given-names>A</given-names></name></person-group><article-title>Participation in lung cancer screening programs: are there gender and social differences? A systematic review</article-title><source><italic toggle="yes">Public Health Rev</italic></source><year>2018</year><volume>39</volume><fpage>23</fpage><pub-id pub-id-type="pmid">30128168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40985-018-0100-0</pub-id><pub-id pub-id-type="pmcid">PMC6092821</pub-id></mixed-citation></ref><ref id="bib95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanner</surname><given-names>NT</given-names></name><name name-style="western"><surname>Banas</surname><given-names>E</given-names></name><name name-style="western"><surname>Yeager</surname><given-names>D</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L</given-names></name><name name-style="western"><surname>Hughes Halbert</surname><given-names>C</given-names></name><name name-style="western"><surname>Silvestri</surname><given-names>GA</given-names></name></person-group><article-title>In-person and telephonic shared decision-making visits for people considering lung cancer screening: an assessment of decision quality</article-title><source><italic toggle="yes">Chest</italic></source><year>2019</year><volume>155</volume><fpage>236</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">30616725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2018.07.046</pub-id></mixed-citation></ref><ref id="bib96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crosbie</surname><given-names>PA</given-names></name><name name-style="western"><surname>Balata</surname><given-names>H</given-names></name><name name-style="western"><surname>Evison</surname><given-names>M</given-names></name><name name-style="western"><surname>Atack</surname><given-names>M</given-names></name><name name-style="western"><surname>Bayliss-Brideaux</surname><given-names>V</given-names></name><name name-style="western"><surname>Colligan</surname><given-names>D</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Implementing lung cancer screening: baseline results from a community-based &#8216;Lung Health Check&#8217; pilot in deprived areas of Manchester</article-title><source><italic toggle="yes">Thorax</italic></source><year>2019</year><volume>74</volume><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">29440588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2017-211377</pub-id></mixed-citation></ref><ref id="bib97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeliadt</surname><given-names>SB</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Birkby</surname><given-names>G</given-names></name><name name-style="western"><surname>Eberth</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>AT</given-names></name><name name-style="western"><surname>Reuland</surname><given-names>DS</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Challenges implementing lung cancer screening in federally qualified health centers</article-title><source><italic toggle="yes">Am J Prev Med</italic></source><year>2018</year><volume>54</volume><fpage>568</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">29429606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2018.01.001</pub-id><pub-id pub-id-type="pmcid">PMC8483158</pub-id></mixed-citation></ref><ref id="bib98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shekelle</surname><given-names>PG</given-names></name><name name-style="western"><surname>Morton</surname><given-names>SC</given-names></name><name name-style="western"><surname>Keeler</surname><given-names>EB</given-names></name></person-group><article-title>Costs and benefits of health information technology</article-title><source><italic toggle="yes">Evid Rep Technol Assess (Full Rep)</italic></source><year>2006</year><volume>(132)</volume><fpage>1</fpage><lpage>71</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.23970/ahrqepcerta132</pub-id><pub-id pub-id-type="pmcid">PMC4781594</pub-id><pub-id pub-id-type="pmid">17627328</pub-id></mixed-citation></ref><ref id="bib99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dyer</surname><given-names>DS</given-names></name><name name-style="western"><surname>Zelarney</surname><given-names>PT</given-names></name><name name-style="western"><surname>Carr</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kern</surname><given-names>EO</given-names></name></person-group><article-title>Improvement in follow-up imaging with a patient tracking system and computerized registry for lung nodule management</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2021</year><volume>18</volume><fpage>937</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">33607066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2021.01.018</pub-id></mixed-citation></ref><ref id="bib100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>SK</given-names></name><name name-style="western"><surname>Doshi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Recht</surname><given-names>MP</given-names></name><name name-style="western"><surname>Lover</surname><given-names>AC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DC</given-names></name><name name-style="western"><surname>Moore</surname><given-names>W</given-names></name></person-group><article-title>Process improvement for communication and follow-up of incidental lung nodules</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2020</year><volume>17</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">31899183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2019.11.023</pub-id></mixed-citation></ref><ref id="bib101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortani Barbosa</surname><given-names>EJ</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Kelly</surname><given-names>K</given-names></name></person-group><article-title>Statistical modeling can determine what factors are predictive of appropriate follow-up in patients presenting with incidental pulmonary nodules on CT</article-title><source><italic toggle="yes">Eur J Radiol</italic></source><year>2020</year><volume>128</volume><fpage>109062</fpage><pub-id pub-id-type="pmid">32422551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejrad.2020.109062</pub-id></mixed-citation></ref><ref id="bib102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McPhee</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Bird</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>CN</given-names></name><name name-style="western"><surname>Fordham</surname><given-names>D</given-names></name></person-group><article-title>Promoting cancer screening: a randomized, controlled trial of three interventions</article-title><source><italic toggle="yes">Arch Intern Med</italic></source><year>1989</year><volume>149</volume><fpage>1866</fpage><lpage>1872</lpage><pub-id pub-id-type="pmid">2764657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.149.8.1866</pub-id></mixed-citation></ref><ref id="bib103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cykert</surname><given-names>S</given-names></name><name name-style="western"><surname>Eng</surname><given-names>E</given-names></name><name name-style="western"><surname>Walker</surname><given-names>P</given-names></name><name name-style="western"><surname>Manning</surname><given-names>MA</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>LB</given-names></name><name name-style="western"><surname>Arya</surname><given-names>R</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: a pragmatic trial at five cancer centers</article-title><source><italic toggle="yes">Cancer Med</italic></source><year>2019</year><volume>8</volume><fpage>1095</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">30714689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cam4.2005</pub-id><pub-id pub-id-type="pmcid">PMC6434214</pub-id></mixed-citation></ref><ref id="bib104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harvey</surname><given-names>HB</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Gilman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Vartanians</surname><given-names>V</given-names></name><name name-style="western"><surname>Halpern</surname><given-names>EF</given-names></name><name name-style="western"><surname>Pandharipande</surname><given-names>PV</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Correlation of the strength of recommendations for additional imaging to adherence rate and diagnostic yield</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2015</year><volume>12</volume><fpage>1016</fpage><lpage>1022</lpage><pub-id pub-id-type="pmid">26092592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2015.03.038</pub-id></mixed-citation></ref><ref id="bib105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Percac-Lima</surname><given-names>S</given-names></name><name name-style="western"><surname>Ashburner</surname><given-names>JM</given-names></name><name name-style="western"><surname>Shepard</surname><given-names>JAO</given-names></name><name name-style="western"><surname>Lennes</surname><given-names>IT</given-names></name><name name-style="western"><surname>Rimmelin</surname><given-names>DE</given-names></name><name name-style="western"><surname>Atlas</surname><given-names>SJ</given-names></name></person-group><article-title>Timeliness of recommended follow-up after an abnormal finding on diagnostic chest CT in smokers at high risk of developing lung cancer</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2016</year><volume>13</volume><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">26924163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2016.01.007</pub-id></mixed-citation></ref><ref id="bib106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blagev</surname><given-names>DP</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>JF</given-names></name><name name-style="western"><surname>Conner</surname><given-names>K</given-names></name><name name-style="western"><surname>Dickerson</surname><given-names>J</given-names></name><name name-style="western"><surname>Adams</surname><given-names>D</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>SM</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Follow-up of incidental pulmonary nodules and the radiology report</article-title><source><italic toggle="yes">J Am Coll Radiol</italic></source><year>2014</year><volume>11</volume><fpage>378</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">24316231</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacr.2013.08.003</pub-id></mixed-citation></ref><ref id="bib107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacMahon</surname><given-names>H</given-names></name><name name-style="western"><surname>Naidich</surname><given-names>DP</given-names></name><name name-style="western"><surname>Goo</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KS</given-names></name><name name-style="western"><surname>Leung</surname><given-names>ANC</given-names></name><name name-style="western"><surname>Mayo</surname><given-names>JR</given-names></name><etal>
<italic toggle="yes">et&#160;al.</italic>
</etal></person-group><article-title>Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017</article-title><source><italic toggle="yes">Radiology</italic></source><year>2017</year><volume>284</volume><fpage>228</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">28240562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2017161659</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>